{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 1048820, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:40:52Z", "timestamp": 1574156452920}, "reference-count": 87, "publisher": "Springer Science and Business Media LLC", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neurotherapeutics"], "published-print": {"date-parts": [[2005, 1]]}, "DOI": "10.1602/neurorx.2.1.54", "type": "journal-article", "created": {"date-parts": [[2004, 12, 14]], "date-time": "2004-12-14T18:29:06Z", "timestamp": 1103048946000}, "page": "54-62", "source": "Crossref", "is-referenced-by-count": 111, "title": ["Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems"], "prefix": "10.1007", "volume": "2", "author": [{"given": "Akira", "family": "Tsuji", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "20100054_CR1", "author": "QR Smith", "first-page": "188", "year": "1998", "unstructured": "Smith QR, Stoll J Blood-brain barrier amino acid transport. In: Introduction to the blood-brain barrier (Pardridge WM, ed), pp 188\u2013197. Cambridge, UK: Cambridge University Press, 1998.", "volume-title": "Introduction to the blood-brain barrier", "DOI": "10.1017/CBO9780511570216.020", "doi-asserted-by": "crossref"}, {"key": "20100054_CR2", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1152/physrev.1990.70.1.43", "volume": "70", "author": "HN Christensen", "year": "1990", "unstructured": "Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism.Physiol Rev 70: 43\u201377, 1990.", "journal-title": "Physiol Rev"}, {"key": "20100054_CR3", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1056/NEJM198402233100802", "volume": "310", "author": "JG Nutt", "year": "1984", "unstructured": "Nutt JG, Woodward WR, Hammerstad JP, Carter JH, Anderson JL. The \u201cON-OFF\u201d phenomenon in Parkinson\u2019s disease. Relation to levodopa absorption and transport.N Engl J Med 310: 483\u2013488, 1984.", "journal-title": "N Engl J Med"}, {"key": "20100054_CR4", "doi-asserted-by": "crossref", "first-page": "23629", "DOI": "10.1074/jbc.273.37.23629", "volume": "273", "author": "Y Kanai", "year": "1998", "unstructured": "Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).J Biol Chem 273: 23629\u201323632, 1998.", "journal-title": "J Biol Chem"}, {"key": "20100054_CR5", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1038/26246", "volume": "395", "author": "L Mastroberardino", "year": "1998", "unstructured": "Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, Shoemaker CB et al. Amino acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.Nature 395: 288\u2013291, 1998.", "journal-title": "Nature"}, {"issue": "96", "key": "20100054_CR6", "doi-asserted-by": "crossref", "first-page": "12079", "DOI": "10.1073/pnas.96.21.12079", "volume": "12", "author": "RJ Boado", "year": "1999", "unstructured": "Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM. Selective expression of the large neutral amino acid transporter at the blood-brain barrier.Proc Natl Acad Sci USA 12:96: 12079\u201312084, 1999.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "20100054_CR7", "doi-asserted-by": "crossref", "first-page": "1322", "DOI": "10.1046/j.1471-4159.2003.01622.x", "volume": "84", "author": "RJ Boado", "year": "2003", "unstructured": "Boado RJ, Li JY, Pardridge WM. Site-directed mutagenesis of rabbit LAT1 at amino acids 219 and 234.J Neurochem 84: 1322\u20131323, 2003.", "journal-title": "J Neurochem"}, {"key": "20100054_CR8", "doi-asserted-by": "crossref", "first-page": "19738", "DOI": "10.1074/jbc.274.28.19738", "volume": "274", "author": "M Pineda", "year": "1999", "unstructured": "Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, Camps M, et al. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.J Biol Chem 274: 19738\u201319744, 1999.", "journal-title": "J Biol Chem"}, {"key": "20100054_CR9", "doi-asserted-by": "crossref", "first-page": "19745", "DOI": "10.1074/jbc.274.28.19745", "volume": "274", "author": "H Segawa", "year": "1999", "unstructured": "Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity.J Biol Chem 274: 19745\u201319751, 1999.", "journal-title": "J Biol Chem"}, {"key": "20100054_CR10", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.1211/0022357011775794", "volume": "53", "author": "Y Kido", "year": "2001", "unstructured": "Kido Y, Tamai I, Uchino H, Sai Y, Suzuki F, Tsuji A. Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier.J Pharm Pharmcol 53: 497\u2013503, 2001.", "journal-title": "J Pharm Pharmcol"}, {"key": "20100054_CR11", "doi-asserted-by": "crossref", "first-page": "1481", "DOI": "10.1152/physrev.1983.63.4.1481", "volume": "63", "author": "WM Pardridge", "year": "1983", "unstructured": "Pardridge WM. Brain metabolism: a perspective from the blood-brain barrier.Physiol Rev 63: 1481\u20131535, 1983.", "journal-title": "Physiol Rev"}, {"key": "20100054_CR12", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/0168-0102(95)00876-U", "volume": "22", "author": "T Nishizaki", "year": "1995", "unstructured": "Nishizaki T, Kammesheidt A, Sumikawa K, Asada T, Okada Y. A sodium- and energy-dependent glucose transporter with similarity to SGLT1-2 is expressed in bovine cortical vessels.Neurosci Res 22: 13\u201322, 1995.", "journal-title": "Neurosci Res"}, {"issue": "1193", "key": "20100054_CR13", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1016/0005-2736(94)90328-X", "volume": "91", "author": "AK Kumagai", "year": "1994", "unstructured": "Kumagai AK, Dwyer KJ, Pardridge WM. Differential glycosylation of the GLUT1 glucose transporter in brain capillaries and choroid plexus.Biochim Biophys Acta 91:1193: 24\u201330, 1994.", "journal-title": "Biochim Biophys Acta"}, {"key": "20100054_CR14", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1016/S0008-6215(96)00328-X", "volume": "299", "author": "T Halmos", "year": "1997", "unstructured": "Halmos T, Santarromana M, Antonakis K, Scherman D. Synthesis of O-methylsulfonyl derivatives of D-glucose as potential alkylating agents for targeted drug delivery to the brain. Evaluation of their interaction with the human erythrocyte GLUT1 hexose transporter.Carbohyd Res 299: 15\u201321, 1997.", "journal-title": "Carbohyd Res"}, {"key": "20100054_CR15", "doi-asserted-by": "crossref", "first-page": "1516", "DOI": "10.1038/sj.bjp.0701971", "volume": "124", "author": "L Negri", "year": "1998", "unstructured": "Negri L, Lattanzi R, Tabacco F, Scolaro B, Rocchi R. Glycoder-morphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration.Br J Pharmacol 124: 1516\u20131522, 1998.", "journal-title": "Br J Pharmacol"}, {"key": "20100054_CR16", "first-page": "E207", "volume": "273", "author": "DZ Gerhart", "year": "1997", "unstructured": "Gerhart DZ, Enerson BE, Zhdankina OY, Leino RL, Drews LR. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats.Am J Physiol (Lond) 273: E207-E213, 1997.", "journal-title": "Am J Physiol (Lond)"}, {"key": "20100054_CR17", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1023/A:1007518525161", "volume": "17", "author": "Y Kido", "year": "2000", "unstructured": "Kido Y, Tamai I, Okamoto M, Suzuki F, Tsuji A. Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier of rats using in vivo cultured cells and in vivo BUI studies.Pharm Res 17: 55\u201362, 2000.", "journal-title": "Pharm Res"}, {"key": "20100054_CR18", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1159/000114465", "volume": "6", "author": "WH Oldendolf", "year": "1971", "unstructured": "Oldendolf WH. Blood-brain barrier permeability of lactate.Eur Neurol 6: 49\u201355, 1971.", "journal-title": "Eur Neurol"}, {"key": "20100054_CR19", "first-page": "1450", "volume": "224", "author": "WH Oldendolf", "year": "1973", "unstructured": "Oldendolf WH. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids.Am J Physiol (Lond) 224: 1450\u20131453, 1973.", "journal-title": "Am J Physiol (Lond)"}, {"key": "20100054_CR20", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1161/01.STR.5.1.81", "volume": "5", "author": "EM Nemoto", "year": "1997", "unstructured": "Nemoto EM, Severinghaus JW. Stereopecfic permeability of rat blood-brain barrier to lactic acid.Stroke 5: 81\u201384, 1997.", "journal-title": "Stroke"}, {"key": "20100054_CR21", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1248/bpb1978.13.158", "volume": "13", "author": "YS Kang", "year": "1990", "unstructured": "Kang YS, Terasaki T, Tsuji A. Acidic drug transport in vivo through the blood-brain barrier: a role of the transport carrier for monocarboxylic acids.J Pharmacobiodyn 13: 158\u2013163, 1990.", "journal-title": "J Pharmacobiodyn"}, {"key": "20100054_CR22", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1111/j.2042-7158.1991.tb06660.x", "volume": "43", "author": "T Terasaki", "year": "1991", "unstructured": "Terasaki T, Kang YS, Ohnishi T, Tsuji A. In-vitro evidence for carrier-mediated uptake of acidic drugs by isolated bovine brain capillaries.J Pharm Pharmacol 43: 172\u2013176, 1991.", "journal-title": "J Pharm Pharmacol"}, {"key": "20100054_CR23", "first-page": "932", "volume": "258", "author": "T Terasaki", "year": "1991", "unstructured": "Terasaki T, Takakuwa S, Moritani S, Tsuji A. Transport of monocarboxylic acids at the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells.J Pharmacol Exp Ther 258: 932\u2013937, 1991.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR24", "doi-asserted-by": "crossref", "first-page": "1531", "DOI": "10.1002/jps.10389", "volume": "92", "author": "B Enerson", "year": "2003", "unstructured": "Enerson B, Drewes LR. Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery.J Pharm Sci 92: 1531\u20131544, 2003.", "journal-title": "J Pharm Sci"}, {"key": "20100054_CR25", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1211/0022357991776804", "volume": "51", "author": "I Tamai", "year": "1999", "unstructured": "Tamai I, Sai Y, Ono A, Kido Y, Yabuuchi H, Takanaga H, et al. Immunohistochemical and functional characterization of pH-dependent intestinal absorption of organic weak acids by monocarboxylic acid transporter MCT1.J Pharm Pharmacol 51: 113\u20131121, 1999.", "journal-title": "J Pharm Pharmacol"}, {"key": "20100054_CR26", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1016/0092-8674(94)90361-1", "volume": "76", "author": "CK Garcia", "year": "1994", "unstructured": "Garcia CK, Goldstein JL, Oathak RK, Anderson RG, Brown MS. Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle.Cell 76: 865\u2013873, 1994.", "journal-title": "Cell"}, {"key": "20100054_CR27", "first-page": "551", "volume": "280", "author": "Y Deguchi", "year": "1997", "unstructured": "Deguchi Y, Nozawa K, Yamada S, Yokoyama Y, Kimura R. Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: possible involvement of the monocarboxylic acid transport system.J Pharmacol Exp Ther 280: 551\u2013560, 1997.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR28", "doi-asserted-by": "crossref", "first-page": "649", "DOI": "10.1016/S0024-3205(99)00637-2", "volume": "66", "author": "Y Deguchi", "year": "2000", "unstructured": "Deguchi Y, Yokoyama Y, Sakamoto T, Hayashi H, Naito T, Yamada S, et al. Brain distribution of 6-mercaptopurine is regulated by the efflux transport system in the blood-brain barrier.Life Sci 66: 649\u2013662, 2000.", "journal-title": "Life Sci"}, {"key": "20100054_CR29", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/S0169-409X(02)00172-2", "volume": "55", "author": "H Sun", "year": "2003", "unstructured": "Sun H, Dai H, Shaik N, Elmquist WE. Drug efflux transporters in the CNS.Adv Drug Deliv Rev 55: 83\u2013105, 2003.", "journal-title": "Adv Drug Deliv Rev"}, {"key": "20100054_CR30", "doi-asserted-by": "crossref", "first-page": "1541", "DOI": "10.1111/j.1471-4159.1985.tb08793.x", "volume": "44", "author": "EM Cornford", "year": "1985", "unstructured": "Cornford EM, Diep CP, Pardridge WM. Blood-brain barrier transport of valproic acid.J Neurochem 44: 1541\u20131550, 1985.", "journal-title": "J Neurochem"}, {"key": "20100054_CR31", "first-page": "1189", "volume": "276", "author": "KDK Adkison", "year": "1996", "unstructured": "Adkison KDK, Shen DD. Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter.J Pharmacol Exp Ther 276: 1189\u20131200, 1996.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR32", "doi-asserted-by": "crossref", "first-page": "18526", "DOI": "10.1074/jbc.272.30.18526", "volume": "272", "author": "T Sekine", "year": "1997", "unstructured": "Sekine T, Watanabe T, Hosoyamada M, Kanai Y, Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter.J Biol Chem 272: 18526\u201318529, 1997.", "journal-title": "J Biol Chem"}, {"key": "20100054_CR33", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1007/s004240000297", "volume": "400", "author": "T Sekine", "year": "2000", "unstructured": "Sekine T, Cha SH, Endou H. The multispecific organic anion transporter (OAT) family.Eur J Physiol (Lond) 400: 337\u2013350, 2000.", "journal-title": "Eur J Physiol (Lond)"}, {"key": "20100054_CR34", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1007/s004240000297", "volume": "440", "author": "T Sekine", "year": "2000", "unstructured": "Sekine T, Cha SH, Endou H. The multispecific organic anion transporter (OAT) family.Pflugers Arch-Eur J Physiol (Lond) 440: 337\u2013350, 2000.", "journal-title": "Pflugers Arch-Eur J Physiol (Lond)"}, {"key": "20100054_CR35", "doi-asserted-by": "crossref", "first-page": "1255", "DOI": "10.1177/002215549904701005", "volume": "47", "author": "B Gao", "year": "1999", "unstructured": "Gao B, Stieger B, Now B, Fritschy JM, Meier PJ. Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain.J Histochem Cytochem 47: 1255\u20131264, 1999.", "journal-title": "J Histochem Cytochem"}, {"key": "20100054_CR36", "first-page": "231", "volume": "17", "author": "B Hagenbuch", "year": "2002", "unstructured": "Hagenbuch B, Gao B, Meier PJ. Transport of xenobiotics across the blood-bran barrier.News Physiol Sci 17: 231\u2013234, 2002.", "journal-title": "News Physiol Sci"}, {"key": "20100054_CR37", "doi-asserted-by": "crossref", "first-page": "13675", "DOI": "10.1074/jbc.274.19.13675", "volume": "274", "author": "H Kusuhara", "year": "1999", "unstructured": "Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Sugiyama Y, Kanai K, Endou H. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain.J Biol Chem 274: 13675\u201313680, 1999.", "journal-title": "J Biol Chem"}, {"key": "20100054_CR38", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1006/bbrc.2000.2922", "volume": "273", "author": "I Tamai", "year": "2000", "unstructured": "Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, et al. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.Biochem Biophys Res Commun 273: 251\u2013260, 2000.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "20100054_CR39", "doi-asserted-by": "crossref", "first-page": "1262", "DOI": "10.1023/A:1013077609227", "volume": "18", "author": "I Tamai", "year": "2001", "unstructured": "Tamai I, Nozawa T, Koshida M, Nezu J, Sai Y, Tsuji A. Functional characterization of human organic anion transporting polypeptide OATP-B in comparison with liver-specific OATP-C.Pharm Res 18: 1262\u20131269, 2001.", "journal-title": "Pharm Res"}, {"key": "20100054_CR40", "unstructured": "Gao B, Vavricha S, Huber RD, Meier PJ. Differential cellular localization of organic anion transporting polypeptides in human brain and retina. PharmConference, Abstract P12, Pontresina, Switzerland, 2003."}, {"key": "20100054_CR41", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1124/jpet.103.051300", "volume": "306", "author": "D Kobayashi", "year": "2003", "unstructured": "Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I. Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.J Pharmacol Exp Ther 306: 703\u2013708, 2003.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR42", "doi-asserted-by": "crossref", "first-page": "438", "DOI": "10.1124/jpet.103.060194", "volume": "308", "author": "T Nozawa", "year": "2004", "unstructured": "Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I. Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human.J Pharmacol Exp Ther 308: 438\u2013445, 2004.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR43", "first-page": "1085", "volume": "267", "author": "A Tsuji", "year": "1993", "unstructured": "Tsuji A, Saheki A, Tamai I, Terasaki T. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier.J Pharmacol Exp Ther 267: 1085\u20131090, 1993.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR44", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1023/A:1018975928974", "volume": "11", "author": "A Saheki", "year": "1994", "unstructured": "Saheki A, Terasaki T, Tamai I, Tsuji A. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.Pharm Res 11: 305\u2013311, 1994.", "journal-title": "Pharm Res"}, {"key": "20100054_CR45", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1146/annurev.pharmtox.38.1.431", "volume": "38", "author": "L Zhang", "year": "1998", "unstructured": "Zhang L, Brett CM, GiacoMmini KM. Role of organic cation transporters in drug absorption and elimination.Annu Rev Pharmacol Toxicol 38: 431\u2013460, 1998.", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "20100054_CR46", "doi-asserted-by": "crossref", "first-page": "342", "DOI": "10.1124/mol.54.2.342", "volume": "54", "author": "AE Busch", "year": "1998", "unstructured": "Busch AE, Karbach U, Miska D, Gorboulev V, Akhoundova A, Volk C, et al. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.Mol Pharmacol 54: 342\u2013352, 1998.", "journal-title": "Mol Pharmacol"}, {"key": "20100054_CR47", "doi-asserted-by": "crossref", "first-page": "32776", "DOI": "10.1074/jbc.273.49.32776", "volume": "273", "author": "X Wu", "year": "1998", "unstructured": "Wu X, Kekuda R, Huang W, Fei Y-J, Leibach FH, Chen J, et al. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter and evidence for the expression of the transporter in the brain.J Biol Chem 273: 32776\u201332786, 1998.", "journal-title": "J Biol Chem"}, {"key": "20100054_CR48", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/S0014-5793(97)01441-5", "volume": "419", "author": "I Tamai", "year": "1997", "unstructured": "Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1.FEBS Lett 419: 107\u2013111, 1997.", "journal-title": "FEBS Lett"}, {"key": "20100054_CR49", "doi-asserted-by": "crossref", "first-page": "40064", "DOI": "10.1074/jbc.M005340200", "volume": "275", "author": "I Tamai", "year": "2000", "unstructured": "Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, Oku A, Shimane M, Tsuji A. Molecular and functional characterization of organic cation/camitine transporter family in mice.J Biol Chem 275: 40064\u201340072, 2000.", "journal-title": "J Biol Chem"}, {"key": "20100054_CR50", "doi-asserted-by": "crossref", "first-page": "20378", "DOI": "10.1074/jbc.273.32.20378", "volume": "273", "author": "I Tamai", "year": "1998", "unstructured": "Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, et al. Molecular and functional identification of sodium ion-dependent high affinity human camitine transporter OCTN2.J Biol Chem 273: 20378\u201320382, 1998.", "journal-title": "J Biol Chem"}, {"key": "20100054_CR51", "doi-asserted-by": "crossref", "first-page": "586", "DOI": "10.1006/bbrc.1998.9521", "volume": "251", "author": "T Sekine", "year": "1998", "unstructured": "Sekine T, Kusuhara H, Utsunomia-Tate N, Tsuda M, Sugiyama Y, Kanai Y, et al. Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine.Biochem Biophys Res Commun 251: 586\u2013591, 1998.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "20100054_CR52", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1038/5030", "volume": "21", "author": "J Nezu", "year": "1999", "unstructured": "Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, et al. Primary systemic camitine deficiency is caused by mutations in a sodium-ion dependent camitine transporter OCTN2.Nat Genet 21: 91\u201394, 1999.", "journal-title": "Nat Genet"}, {"key": "20100054_CR53", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1038/ng1339", "volume": "36", "author": "VD Peltekova", "year": "2004", "unstructured": "Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease.Nat Genet 36: 471\u2013475, 2004.", "journal-title": "Nat Genet"}, {"key": "20100054_CR54", "first-page": "768", "volume": "289", "author": "H Yabuuchi", "year": "1999", "unstructured": "Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.J Pharmacol Exp Ther 289: 768\u2013773, 1999.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR55", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1006/bbrc.1998.8669", "volume": "246", "author": "X Wu", "year": "1998", "unstructured": "Wu X, Prasado PD, Leibach FH, Ganapathy V. cDNA sequence, transport function, and geneomic organization of human OCTN2, a new member of the organic cation transporter family.Biochem Biophy Res Commun 246: 589\u2013595, 1998.", "journal-title": "Biochem Biophy Res Commun"}, {"key": "20100054_CR56", "first-page": "1482", "volume": "290", "author": "X Wu", "year": "1999", "unstructured": "Wu X, Huang W, Prasado PD, Seth P, Rajan DP, Leibach FH, et al. Functional characterization and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/camitine transporter.J Pharmacol Exp Ther 290: 1482\u20131492, 1999.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR57", "first-page": "778", "volume": "291", "author": "R Ohashi", "year": "1999", "unstructured": "Ohashi R, Tamai I, Yabuuchi H, Nezu JI, Oku A, Sai Y, Shimane M, Tsuji A. Na(+)-dependent camitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.J Pharmacol Exp Ther 291: 778\u2013784, 1999.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR58", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1124/mol.59.2.358", "volume": "59", "author": "R Ohashi", "year": "2001", "unstructured": "Ohashi R, Tamai I, Nezu J, Nikaido H, Hashimoto N, Oku A, et al. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.Mol Pharmacol 59: 358\u2013366, 2001.", "journal-title": "Mol Pharmacol"}, {"key": "20100054_CR59", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/S0006-8993(02)04271-3", "volume": "968", "author": "A Friedlich", "year": "2003", "unstructured": "Friedlich A, Prasasd PD, Freyer D, Ganapathy V, Brust P. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.Brain Res 968: 69\u201379, 2003.", "journal-title": "Brain Res"}, {"key": "20100054_CR60", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1002/bdd.371", "volume": "24", "author": "A Inano", "year": "2003", "unstructured": "Inano A, Sai Y, Nikaido H, Hasimoto N, Asano M, Tsuji A. Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2. Biopharm Drug Dispos 24: 357\u2013365, 2003.", "journal-title": "Biopharm Drug Dispos"}, {"key": "20100054_CR61", "doi-asserted-by": "crossref", "first-page": "676", "DOI": "10.1248/bpb.17.676", "volume": "17", "author": "M Yamazaki", "year": "1994", "unstructured": "Yamazaki M, Fukuoka H, Nagata O, Kato H, Ito Y, Terasaki T, Tsuji A. Transport mechanism of an H1-antagonist at the blood-brain barrier: transport mechanism of mepyramine using carotid injection technique.Biol Pharm Bull 17: 676\u2013679, 1994.", "journal-title": "Biol Pharm Bull"}, {"key": "20100054_CR62", "doi-asserted-by": "crossref", "first-page": "975", "DOI": "10.1023/A:1018923017954", "volume": "11", "author": "M Yamazaki", "year": "1994", "unstructured": "Yamazaki M, Terasaki T, Yoshioka K, Nagata O, Kato H, Ito Y, et al. Carrier-mediated transport of H1-antagonist at the blood-brain barrier: mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures.Pharm Res 11: 975\u2013978, 1994.", "journal-title": "Pharm Res"}, {"key": "20100054_CR63", "doi-asserted-by": "crossref", "first-page": "1516", "DOI": "10.1023/A:1018980914687", "volume": "11", "author": "M Yamazaki", "year": "1994", "unstructured": "Yamazaki M, Terasaki T, Yoshioka K, Nagata O, Kato H, Ito Y, et al. Carrier-mediated transport of H1-antagonist at the blood-brain barrier: a common transport system of H1-antagonists and lipophilic basic drugs.Pharm Res 11: 1516\u20131518, 1994.", "journal-title": "Pharm Res"}, {"key": "20100054_CR64", "first-page": "866", "volume": "27", "author": "M Cvetkovic", "year": "1999", "unstructured": "Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.Drug Metab Dispos 27: 866\u2013871, 1999.", "journal-title": "Drug Metab Dispos"}, {"key": "20100054_CR65", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.1111/j.1365-2125.1988.tb05288.x", "volume": "26", "author": "J Vincent", "year": "1998", "unstructured": "Vincent J, Liminana R, Meredith PA, Reid JL. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.Br J Clin Pharmacol 26: 497\u2013502, 1998.", "journal-title": "Br J Clin Pharmacol"}, {"key": "20100054_CR66", "first-page": "55", "volume": "44", "author": "M Matsuda", "year": "1994", "unstructured": "Matsuda M, Sakashita M, Mizuki Y, Yamaguchi T, Fujii T, Sekine Y. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.Arzneim-Forsch/Drug Res 44: 55\u201359, 1994.", "journal-title": "Arzneim-Forsch/Drug Res"}, {"key": "20100054_CR67", "first-page": "59", "volume": "44", "author": "T Yamaguchi", "year": "1994", "unstructured": "Yamaguchi T, Hashizume T, Matsuda M, Sakashita M, Fujii T, Sekine Y, et al. Pharmacokinetics of the Hl-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects. Arzneimittelforschung 44: 59\u201364, 1994.", "journal-title": "Arzneimittelforschung"}, {"key": "20100054_CR68", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.3109/10611860008997914", "volume": "8", "author": "I Tamai", "year": "2000", "unstructured": "Tamai I, Kido Y, Yamashita J, Sai Y, Tsuji A. Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.J Drug Target 8: 383\u2013393, 2000.", "journal-title": "J Drug Target"}, {"key": "20100054_CR69", "first-page": "81", "volume": "282", "author": "J Huwyler", "year": "1997", "unstructured": "Huwyler J, Flicker G, Torok M, Schneider M, Drewe J. Transport of clonidine across cultured brain microvessel endothelial cells.J Pharmacol Exp Ther 282: 81\u201385, 1997.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR70", "first-page": "1084", "volume": "289", "author": "TK Henthom", "year": "1999", "unstructured": "Henthom TK, Liu Y, Mahapatro M, Ng KY. Active transport of fentanyl by the blood-brain barrier.J Pharmacol Exp Ther 289: 1084\u20131089, 1999.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR71", "doi-asserted-by": "crossref", "first-page": "1351", "DOI": "10.1248/bpb.25.1351", "volume": "25", "author": "T Suzuki", "year": "2002", "unstructured": "Suzuki T, Moriki Y, Goto H, Tomono K, Hanano M, Watanabe J. Investigation on the influx transport mechanism of pentazocine at the blood-brain barrier in rats using the carotid injection technique.Biol Pharm Bull 25: 1351\u20131355, 2002.", "journal-title": "Biol Pharm Bull"}, {"key": "20100054_CR72", "doi-asserted-by": "crossref", "first-page": "932", "DOI": "10.1248/bpb.27.932", "volume": "27", "author": "Y Moriki", "year": "2004", "unstructured": "Moriki Y, Suzuki T, Fukami T, Hanano M, Tomono K, Watanabe J. Involvement of P-glycoprotein in blood-brain barrier transport of pentazocine in rats using brain uptake index method.Biol Pharm Bull 27: 932\u2013935, 2004.", "journal-title": "Biol Pharm Bull"}, {"key": "20100054_CR73", "doi-asserted-by": "crossref", "first-page": "1289", "DOI": "10.1016/0196-9781(92)90037-4", "volume": "13", "author": "WA Banks", "year": "1992", "unstructured": "Banks WA, Audus K, Davis TP. Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs.Peptides 13: 1289\u20131294, 1992.", "journal-title": "Peptides"}, {"key": "20100054_CR74", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1111/j.2042-7158.1996.tb07112.x", "volume": "48", "author": "DJ Begley", "year": "1996", "unstructured": "Begley DJ. The blood-brain barrier: principle for targeting peptides and drugs to the central nervous system.J Pharm Pharmacol 48: 136\u2013146, 1996.", "journal-title": "J Pharm Pharmacol"}, {"key": "20100054_CR75", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1111/j.1471-4159.1988.tb04864.x", "volume": "51", "author": "BV Zlokovic", "year": "1988", "unstructured": "Zlokovic, BV, Lipovac MN, Begley DJ, Davson H, Rakic L. Slow penetration of thyrotropine-releasing hormone across the blood-brain barrier of an in situ perfused guinea pig brain.J Neurochem 51: 252\u2013257, 1988.", "journal-title": "J Neurochem"}, {"key": "20100054_CR76", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1016/0005-2736(90)90097-8", "volume": "1025", "author": "BV Zlokovic", "year": "1990", "unstructured": "Zlokovic BV, Hyman S, McComb JG, Lipovac MN, Tang G, Davson H. Kinetics of arginine-vasopressin uptake at the blood-brain barrier.Biochim Biophys Acta 1025: 191\u2013198, 1990.", "journal-title": "Biochim Biophys Acta"}, {"key": "20100054_CR77", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1016/0361-9230(87)90048-7", "volume": "19", "author": "CM Barrera", "year": "1987", "unstructured": "Barrera CM, Kastin AJ, Banks WA. D-[Ala1]-peptide T-amide is transported from blood to brain by saturable system.Brain Res Bull 19: 629\u2013633, 1987.", "journal-title": "Brain Res Bull"}, {"key": "20100054_CR78", "doi-asserted-by": "crossref", "first-page": "262", "DOI": "10.1007/BF00177572", "volume": "96", "author": "JF Wilson", "year": "1988", "unstructured": "Wilson JF. Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive \u03b1-melanotropin.Psychopharmacol 96: 262\u2013266, 1988.", "journal-title": "Psychopharmacol"}, {"key": "20100054_CR79", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/0006-8993(84)91088-6", "volume": "301", "author": "WA Banks", "year": "1984", "unstructured": "Banks WA, Kastin AJ, Coy DH. Evidence that125I-N-Tyr-\u03b4 sleeping peptide crosses the blood-brain barrier by a noncompetitive mechanism.Brain Res 301: 201\u2013207, 1984.", "journal-title": "Brain Res"}, {"key": "20100054_CR80", "first-page": "73", "volume": "294", "author": "B Gao", "year": "2000", "unstructured": "Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.J Pharmacol Exp Ther 294: 73\u201379, 2000.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR81", "first-page": "E1", "volume": "259", "author": "R Kannan", "year": "1990", "unstructured": "Kannan R, Kuhlenkamp JF, Jeandidier E, Trinh H, Ookhtens M, Kaplowitz N. Evidence for carrier-mediated transport for glutathi-one across the blood-brain barrier in the rat.Am J Physiol (Lond) 259: E1-E10, 1990.", "journal-title": "Am J Physiol (Lond)"}, {"key": "20100054_CR82", "first-page": "964", "volume": "263", "author": "R Kannan", "year": "1992", "unstructured": "Kannan R, Kuhlenkamp JF, Ookhtens M, Kaplowitz N. Transport of glutathione at the blood-brain barrier of the rat: inhibition by glutathione analogues and age-dependence.J Pharmacol Exp Ther 263: 964\u2013970, 1992.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR83", "doi-asserted-by": "crossref", "first-page": "402", "DOI": "10.1006/bbrc.1994.1715", "volume": "201", "author": "BV Zlokovic", "year": "1994", "unstructured": "Zlokovic BV, Mackic JB, McComb JG, Weiss MH, Kaplowitz N, Kannan R. Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain.Biochem Biophys Res Commun 201: 402\u2013408, 1994.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "20100054_CR84", "doi-asserted-by": "crossref", "first-page": "9754", "DOI": "10.1074/jbc.271.16.9754", "volume": "271", "author": "R Kannan", "year": "1996", "unstructured": "Kannan R, Yi JR, Tang D, Li Y, Zlokovic BV, Kaplowitz N. Evidence for the existence of a sodium-dependent glutathione (GSH) transporter. Expression of bovine brain capillary mRNA and size fractions inXenopus laevis oocytes and dissociation from \u03b3-glutamyltranspeptidase and facilitative GSH transporters.J Biol Chem 271: 9754\u20139758, 1996.", "journal-title": "J Biol Chem"}, {"key": "20100054_CR85", "doi-asserted-by": "crossref", "first-page": "390", "DOI": "10.1046/j.1471-4159.1999.0730390.x", "volume": "73", "author": "R Kannan", "year": "1999", "unstructured": "Kannan R, Mittur A, Bao Y, Tsuruo T, Kaplowitz N. GSH transport in immortalized mouse brain endothelial cells: evidence for apical localization of a sodium-dependent GSH transporter.J Neurochem 73: 390\u2013399, 1999.", "journal-title": "J Neurochem"}, {"key": "20100054_CR86", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1124/jpet.102.046243", "volume": "305", "author": "H Toyobuku", "year": "2003", "unstructured": "Toyobuku H, Sai Y, Kagami T, Tamai I, Tsuji A. Delivery of peptide drugs to the brain by adenovirus-mediated heterologous expression of human oligopeptide transporter at the blood-brain barrier.J Pharmacol Exp Ther 305: 40\u201347, 2003.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "20100054_CR87", "doi-asserted-by": "crossref", "first-page": "174", "DOI": "10.1016/S0167-4889(97)00096-7", "volume": "1359", "author": "R Schlapbach", "year": "1997", "unstructured": "Schlapbach R, Fontana, A. Differential activity of bc1\u20132 and ICE enzyme family protease inhibitors on Fas and puromycin-induced apoptosis of glioma cells.Biochim Biophys Acta 1359: 174\u2013180, 1997.", "journal-title": "Biochim Biophys Acta"}], "container-title": ["NeuroRX"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1602/neurorx.2.1.54", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 1]], "date-time": "2019-01-01T10:25:50Z", "timestamp": 1546338350000}, "score": 86.01584, "issued": {"date-parts": [[2005, 1]]}, "references-count": 87, "journal-issue": {"published-print": {"date-parts": [[2005, 1]]}, "issue": "1"}, "alternative-id": ["20100054"], "URL": "http://dx.doi.org/10.1602/neurorx.2.1.54", "relation": {"cites": []}, "ISSN": ["1545-5343"], "issn-type": [{"value": "1545-5343", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T22:10:30Z", "timestamp": 1576793430984}, "reference-count": 87, "publisher": "Springer Science and Business Media LLC", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neurotherapeutics"], "published-print": {"date-parts": [[2005, 1]]}, "DOI": "10.1007/bf03206642", "type": "journal-article", "created": {"date-parts": [[2011, 1, 31]], "date-time": "2011-01-31T22:25:45Z", "timestamp": 1296512745000}, "page": "54-62", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems"], "prefix": "10.1007", "volume": "2", "author": [{"given": "Akira", "family": "Tsuji", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "BF03206642_CR1", "author": "QR Smith", "first-page": "188", "year": "1998", "unstructured": "Smith QR, Stoll J Blood-brain barrier amino acid transport. In: Introduction to the blood-brain barrier (Pardridge WM, ed), pp 188\u2013197. Cambridge, UK: Cambridge University Press, 1998.", "volume-title": "Introduction to the blood-brain barrier", "DOI": "10.1017/CBO9780511570216.020", "doi-asserted-by": "crossref"}, {"key": "BF03206642_CR2", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1152/physrev.1990.70.1.43", "volume": "70", "author": "HN Christensen", "year": "1990", "unstructured": "Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism.Physiol Rev 70: 43\u201377, 1990.", "journal-title": "Physiol Rev"}, {"key": "BF03206642_CR3", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1056/NEJM198402233100802", "volume": "310", "author": "JG Nutt", "year": "1984", "unstructured": "Nutt JG, Woodward WR, Hammerstad JP, Carter JH, Anderson JL. The \u201cON-OFF\u201d phenomenon in Parkinson\u2019s disease. Relation to levodopa absorption and transport.N Engl J Med 310: 483\u2013488, 1984.", "journal-title": "N Engl J Med"}, {"key": "BF03206642_CR4", "doi-asserted-by": "crossref", "first-page": "23629", "DOI": "10.1074/jbc.273.37.23629", "volume": "273", "author": "Y Kanai", "year": "1998", "unstructured": "Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).J Biol Chem 273: 23629\u201323632, 1998.", "journal-title": "J Biol Chem"}, {"key": "BF03206642_CR5", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1038/26246", "volume": "395", "author": "L Mastroberardino", "year": "1998", "unstructured": "Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, Shoemaker CB et al. Amino acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.Nature 395: 288\u2013291, 1998.", "journal-title": "Nature"}, {"issue": "96", "key": "BF03206642_CR6", "doi-asserted-by": "crossref", "first-page": "12079", "DOI": "10.1073/pnas.96.21.12079", "volume": "12", "author": "RJ Boado", "year": "1999", "unstructured": "Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM. Selective expression of the large neutral amino acid transporter at the blood-brain barrier.Proc Natl Acad Sci USA 12:96: 12079\u201312084, 1999.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF03206642_CR7", "doi-asserted-by": "crossref", "first-page": "1322", "DOI": "10.1046/j.1471-4159.2003.01622.x", "volume": "84", "author": "RJ Boado", "year": "2003", "unstructured": "Boado RJ, Li JY, Pardridge WM. Site-directed mutagenesis of rabbit LAT1 at amino acids 219 and 234.J Neurochem 84: 1322\u20131323, 2003.", "journal-title": "J Neurochem"}, {"key": "BF03206642_CR8", "doi-asserted-by": "crossref", "first-page": "19738", "DOI": "10.1074/jbc.274.28.19738", "volume": "274", "author": "M Pineda", "year": "1999", "unstructured": "Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, Camps M, et al. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.J Biol Chem 274: 19738\u201319744, 1999.", "journal-title": "J Biol Chem"}, {"key": "BF03206642_CR9", "doi-asserted-by": "crossref", "first-page": "19745", "DOI": "10.1074/jbc.274.28.19745", "volume": "274", "author": "H Segawa", "year": "1999", "unstructured": "Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity.J Biol Chem 274: 19745\u201319751, 1999.", "journal-title": "J Biol Chem"}, {"key": "BF03206642_CR10", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.1211/0022357011775794", "volume": "53", "author": "Y Kido", "year": "2001", "unstructured": "Kido Y, Tamai I, Uchino H, Sai Y, Suzuki F, Tsuji A. Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier.J Pharm Pharmcol 53: 497\u2013503, 2001.", "journal-title": "J Pharm Pharmcol"}, {"key": "BF03206642_CR11", "doi-asserted-by": "crossref", "first-page": "1481", "DOI": "10.1152/physrev.1983.63.4.1481", "volume": "63", "author": "WM Pardridge", "year": "1983", "unstructured": "Pardridge WM. Brain metabolism: a perspective from the blood-brain barrier.Physiol Rev 63: 1481\u20131535, 1983.", "journal-title": "Physiol Rev"}, {"key": "BF03206642_CR12", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/0168-0102(95)00876-U", "volume": "22", "author": "T Nishizaki", "year": "1995", "unstructured": "Nishizaki T, Kammesheidt A, Sumikawa K, Asada T, Okada Y. A sodium- and energy-dependent glucose transporter with similarity to SGLT1-2 is expressed in bovine cortical vessels.Neurosci Res 22: 13\u201322, 1995.", "journal-title": "Neurosci Res"}, {"issue": "1193", "key": "BF03206642_CR13", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1016/0005-2736(94)90328-X", "volume": "91", "author": "AK Kumagai", "year": "1994", "unstructured": "Kumagai AK, Dwyer KJ, Pardridge WM. Differential glycosylation of the GLUT1 glucose transporter in brain capillaries and choroid plexus.Biochim Biophys Acta 91:1193: 24\u201330, 1994.", "journal-title": "Biochim Biophys Acta"}, {"key": "BF03206642_CR14", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1016/S0008-6215(96)00328-X", "volume": "299", "author": "T Halmos", "year": "1997", "unstructured": "Halmos T, Santarromana M, Antonakis K, Scherman D. Synthesis of O-methylsulfonyl derivatives of D-glucose as potential alkylating agents for targeted drug delivery to the brain. Evaluation of their interaction with the human erythrocyte GLUT1 hexose transporter.Carbohyd Res 299: 15\u201321, 1997.", "journal-title": "Carbohyd Res"}, {"key": "BF03206642_CR15", "doi-asserted-by": "crossref", "first-page": "1516", "DOI": "10.1038/sj.bjp.0701971", "volume": "124", "author": "L Negri", "year": "1998", "unstructured": "Negri L, Lattanzi R, Tabacco F, Scolaro B, Rocchi R. Glycoder-morphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration.Br J Pharmacol 124: 1516\u20131522, 1998.", "journal-title": "Br J Pharmacol"}, {"key": "BF03206642_CR16", "first-page": "E207", "volume": "273", "author": "DZ Gerhart", "year": "1997", "unstructured": "Gerhart DZ, Enerson BE, Zhdankina OY, Leino RL, Drews LR. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats.Am J Physiol (Lond) 273: E207-E213, 1997.", "journal-title": "Am J Physiol (Lond)"}, {"key": "BF03206642_CR17", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1023/A:1007518525161", "volume": "17", "author": "Y Kido", "year": "2000", "unstructured": "Kido Y, Tamai I, Okamoto M, Suzuki F, Tsuji A. Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier of rats using in vivo cultured cells and in vivo BUI studies.Pharm Res 17: 55\u201362, 2000.", "journal-title": "Pharm Res"}, {"key": "BF03206642_CR18", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1159/000114465", "volume": "6", "author": "WH Oldendolf", "year": "1971", "unstructured": "Oldendolf WH. Blood-brain barrier permeability of lactate.Eur Neurol 6: 49\u201355, 1971.", "journal-title": "Eur Neurol"}, {"key": "BF03206642_CR19", "doi-asserted-by": "crossref", "first-page": "1450", "DOI": "10.1152/ajplegacy.1973.224.6.1450", "volume": "224", "author": "WH Oldendolf", "year": "1973", "unstructured": "Oldendolf WH. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids.Am J Physiol (Lond) 224: 1450\u20131453, 1973.", "journal-title": "Am J Physiol (Lond)"}, {"key": "BF03206642_CR20", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1161/01.STR.5.1.81", "volume": "5", "author": "EM Nemoto", "year": "1997", "unstructured": "Nemoto EM, Severinghaus JW. Stereopecfic permeability of rat blood-brain barrier to lactic acid.Stroke 5: 81\u201384, 1997.", "journal-title": "Stroke"}, {"key": "BF03206642_CR21", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1248/bpb1978.13.158", "volume": "13", "author": "YS Kang", "year": "1990", "unstructured": "Kang YS, Terasaki T, Tsuji A. Acidic drug transport in vivo through the blood-brain barrier: a role of the transport carrier for monocarboxylic acids.J Pharmacobiodyn 13: 158\u2013163, 1990.", "journal-title": "J Pharmacobiodyn"}, {"key": "BF03206642_CR22", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1111/j.2042-7158.1991.tb06660.x", "volume": "43", "author": "T Terasaki", "year": "1991", "unstructured": "Terasaki T, Kang YS, Ohnishi T, Tsuji A. In-vitro evidence for carrier-mediated uptake of acidic drugs by isolated bovine brain capillaries.J Pharm Pharmacol 43: 172\u2013176, 1991.", "journal-title": "J Pharm Pharmacol"}, {"key": "BF03206642_CR23", "first-page": "932", "volume": "258", "author": "T Terasaki", "year": "1991", "unstructured": "Terasaki T, Takakuwa S, Moritani S, Tsuji A. Transport of monocarboxylic acids at the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells.J Pharmacol Exp Ther 258: 932\u2013937, 1991.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR24", "doi-asserted-by": "crossref", "first-page": "1531", "DOI": "10.1002/jps.10389", "volume": "92", "author": "B Enerson", "year": "2003", "unstructured": "Enerson B, Drewes LR. Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery.J Pharm Sci 92: 1531\u20131544, 2003.", "journal-title": "J Pharm Sci"}, {"key": "BF03206642_CR25", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1211/0022357991776804", "volume": "51", "author": "I Tamai", "year": "1999", "unstructured": "Tamai I, Sai Y, Ono A, Kido Y, Yabuuchi H, Takanaga H, et al. Immunohistochemical and functional characterization of pH-dependent intestinal absorption of organic weak acids by monocarboxylic acid transporter MCT1.J Pharm Pharmacol 51: 113\u20131121, 1999.", "journal-title": "J Pharm Pharmacol"}, {"key": "BF03206642_CR26", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1016/0092-8674(94)90361-1", "volume": "76", "author": "CK Garcia", "year": "1994", "unstructured": "Garcia CK, Goldstein JL, Oathak RK, Anderson RG, Brown MS. Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle.Cell 76: 865\u2013873, 1994.", "journal-title": "Cell"}, {"key": "BF03206642_CR27", "first-page": "551", "volume": "280", "author": "Y Deguchi", "year": "1997", "unstructured": "Deguchi Y, Nozawa K, Yamada S, Yokoyama Y, Kimura R. Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: possible involvement of the monocarboxylic acid transport system.J Pharmacol Exp Ther 280: 551\u2013560, 1997.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR28", "doi-asserted-by": "crossref", "first-page": "649", "DOI": "10.1016/S0024-3205(99)00637-2", "volume": "66", "author": "Y Deguchi", "year": "2000", "unstructured": "Deguchi Y, Yokoyama Y, Sakamoto T, Hayashi H, Naito T, Yamada S, et al. Brain distribution of 6-mercaptopurine is regulated by the efflux transport system in the blood-brain barrier.Life Sci 66: 649\u2013662, 2000.", "journal-title": "Life Sci"}, {"key": "BF03206642_CR29", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/S0169-409X(02)00172-2", "volume": "55", "author": "H Sun", "year": "2003", "unstructured": "Sun H, Dai H, Shaik N, Elmquist WE. Drug efflux transporters in the CNS.Adv Drug Deliv Rev 55: 83\u2013105, 2003.", "journal-title": "Adv Drug Deliv Rev"}, {"key": "BF03206642_CR30", "doi-asserted-by": "crossref", "first-page": "1541", "DOI": "10.1111/j.1471-4159.1985.tb08793.x", "volume": "44", "author": "EM Cornford", "year": "1985", "unstructured": "Cornford EM, Diep CP, Pardridge WM. Blood-brain barrier transport of valproic acid.J Neurochem 44: 1541\u20131550, 1985.", "journal-title": "J Neurochem"}, {"key": "BF03206642_CR31", "first-page": "1189", "volume": "276", "author": "KDK Adkison", "year": "1996", "unstructured": "Adkison KDK, Shen DD. Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter.J Pharmacol Exp Ther 276: 1189\u20131200, 1996.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR32", "doi-asserted-by": "crossref", "first-page": "18526", "DOI": "10.1074/jbc.272.30.18526", "volume": "272", "author": "T Sekine", "year": "1997", "unstructured": "Sekine T, Watanabe T, Hosoyamada M, Kanai Y, Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter.J Biol Chem 272: 18526\u201318529, 1997.", "journal-title": "J Biol Chem"}, {"key": "BF03206642_CR33", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1007/s004240000297", "volume": "400", "author": "T Sekine", "year": "2000", "unstructured": "Sekine T, Cha SH, Endou H. The multispecific organic anion transporter (OAT) family.Eur J Physiol (Lond) 400: 337\u2013350, 2000.", "journal-title": "Eur J Physiol (Lond)"}, {"key": "BF03206642_CR34", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1007/s004240000297", "volume": "440", "author": "T Sekine", "year": "2000", "unstructured": "Sekine T, Cha SH, Endou H. The multispecific organic anion transporter (OAT) family.Pflugers Arch-Eur J Physiol (Lond) 440: 337\u2013350, 2000.", "journal-title": "Pflugers Arch-Eur J Physiol (Lond)"}, {"key": "BF03206642_CR35", "doi-asserted-by": "crossref", "first-page": "1255", "DOI": "10.1177/002215549904701005", "volume": "47", "author": "B Gao", "year": "1999", "unstructured": "Gao B, Stieger B, Now B, Fritschy JM, Meier PJ. Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain.J Histochem Cytochem 47: 1255\u20131264, 1999.", "journal-title": "J Histochem Cytochem"}, {"key": "BF03206642_CR36", "first-page": "231", "volume": "17", "author": "B Hagenbuch", "year": "2002", "unstructured": "Hagenbuch B, Gao B, Meier PJ. Transport of xenobiotics across the blood-bran barrier.News Physiol Sci 17: 231\u2013234, 2002.", "journal-title": "News Physiol Sci"}, {"key": "BF03206642_CR37", "doi-asserted-by": "crossref", "first-page": "13675", "DOI": "10.1074/jbc.274.19.13675", "volume": "274", "author": "H Kusuhara", "year": "1999", "unstructured": "Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Sugiyama Y, Kanai K, Endou H. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain.J Biol Chem 274: 13675\u201313680, 1999.", "journal-title": "J Biol Chem"}, {"key": "BF03206642_CR38", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1006/bbrc.2000.2922", "volume": "273", "author": "I Tamai", "year": "2000", "unstructured": "Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, et al. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.Biochem Biophys Res Commun 273: 251\u2013260, 2000.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "BF03206642_CR39", "doi-asserted-by": "crossref", "first-page": "1262", "DOI": "10.1023/A:1013077609227", "volume": "18", "author": "I Tamai", "year": "2001", "unstructured": "Tamai I, Nozawa T, Koshida M, Nezu J, Sai Y, Tsuji A. Functional characterization of human organic anion transporting polypeptide OATP-B in comparison with liver-specific OATP-C.Pharm Res 18: 1262\u20131269, 2001.", "journal-title": "Pharm Res"}, {"key": "BF03206642_CR40", "unstructured": "Gao B, Vavricha S, Huber RD, Meier PJ. Differential cellular localization of organic anion transporting polypeptides in human brain and retina. PharmConference, Abstract P12, Pontresina, Switzerland, 2003."}, {"key": "BF03206642_CR41", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1124/jpet.103.051300", "volume": "306", "author": "D Kobayashi", "year": "2003", "unstructured": "Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I. Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.J Pharmacol Exp Ther 306: 703\u2013708, 2003.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR42", "doi-asserted-by": "crossref", "first-page": "438", "DOI": "10.1124/jpet.103.060194", "volume": "308", "author": "T Nozawa", "year": "2004", "unstructured": "Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I. Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human.J Pharmacol Exp Ther 308: 438\u2013445, 2004.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR43", "first-page": "1085", "volume": "267", "author": "A Tsuji", "year": "1993", "unstructured": "Tsuji A, Saheki A, Tamai I, Terasaki T. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier.J Pharmacol Exp Ther 267: 1085\u20131090, 1993.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR44", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1023/A:1018975928974", "volume": "11", "author": "A Saheki", "year": "1994", "unstructured": "Saheki A, Terasaki T, Tamai I, Tsuji A. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.Pharm Res 11: 305\u2013311, 1994.", "journal-title": "Pharm Res"}, {"key": "BF03206642_CR45", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1146/annurev.pharmtox.38.1.431", "volume": "38", "author": "L Zhang", "year": "1998", "unstructured": "Zhang L, Brett CM, GiacoMmini KM. Role of organic cation transporters in drug absorption and elimination.Annu Rev Pharmacol Toxicol 38: 431\u2013460, 1998.", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "BF03206642_CR46", "doi-asserted-by": "crossref", "first-page": "342", "DOI": "10.1124/mol.54.2.342", "volume": "54", "author": "AE Busch", "year": "1998", "unstructured": "Busch AE, Karbach U, Miska D, Gorboulev V, Akhoundova A, Volk C, et al. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.Mol Pharmacol 54: 342\u2013352, 1998.", "journal-title": "Mol Pharmacol"}, {"key": "BF03206642_CR47", "doi-asserted-by": "crossref", "first-page": "32776", "DOI": "10.1074/jbc.273.49.32776", "volume": "273", "author": "X Wu", "year": "1998", "unstructured": "Wu X, Kekuda R, Huang W, Fei Y-J, Leibach FH, Chen J, et al. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter and evidence for the expression of the transporter in the brain.J Biol Chem 273: 32776\u201332786, 1998.", "journal-title": "J Biol Chem"}, {"key": "BF03206642_CR48", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/S0014-5793(97)01441-5", "volume": "419", "author": "I Tamai", "year": "1997", "unstructured": "Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1.FEBS Lett 419: 107\u2013111, 1997.", "journal-title": "FEBS Lett"}, {"key": "BF03206642_CR49", "doi-asserted-by": "crossref", "first-page": "40064", "DOI": "10.1074/jbc.M005340200", "volume": "275", "author": "I Tamai", "year": "2000", "unstructured": "Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, Oku A, Shimane M, Tsuji A. Molecular and functional characterization of organic cation/camitine transporter family in mice.J Biol Chem 275: 40064\u201340072, 2000.", "journal-title": "J Biol Chem"}, {"key": "BF03206642_CR50", "doi-asserted-by": "crossref", "first-page": "20378", "DOI": "10.1074/jbc.273.32.20378", "volume": "273", "author": "I Tamai", "year": "1998", "unstructured": "Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, et al. Molecular and functional identification of sodium ion-dependent high affinity human camitine transporter OCTN2.J Biol Chem 273: 20378\u201320382, 1998.", "journal-title": "J Biol Chem"}, {"key": "BF03206642_CR51", "doi-asserted-by": "crossref", "first-page": "586", "DOI": "10.1006/bbrc.1998.9521", "volume": "251", "author": "T Sekine", "year": "1998", "unstructured": "Sekine T, Kusuhara H, Utsunomia-Tate N, Tsuda M, Sugiyama Y, Kanai Y, et al. Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine.Biochem Biophys Res Commun 251: 586\u2013591, 1998.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "BF03206642_CR52", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1038/5030", "volume": "21", "author": "J Nezu", "year": "1999", "unstructured": "Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, et al. Primary systemic camitine deficiency is caused by mutations in a sodium-ion dependent camitine transporter OCTN2.Nat Genet 21: 91\u201394, 1999.", "journal-title": "Nat Genet"}, {"key": "BF03206642_CR53", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1038/ng1339", "volume": "36", "author": "VD Peltekova", "year": "2004", "unstructured": "Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease.Nat Genet 36: 471\u2013475, 2004.", "journal-title": "Nat Genet"}, {"key": "BF03206642_CR54", "first-page": "768", "volume": "289", "author": "H Yabuuchi", "year": "1999", "unstructured": "Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.J Pharmacol Exp Ther 289: 768\u2013773, 1999.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR55", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1006/bbrc.1998.8669", "volume": "246", "author": "X Wu", "year": "1998", "unstructured": "Wu X, Prasado PD, Leibach FH, Ganapathy V. cDNA sequence, transport function, and geneomic organization of human OCTN2, a new member of the organic cation transporter family.Biochem Biophy Res Commun 246: 589\u2013595, 1998.", "journal-title": "Biochem Biophy Res Commun"}, {"key": "BF03206642_CR56", "first-page": "1482", "volume": "290", "author": "X Wu", "year": "1999", "unstructured": "Wu X, Huang W, Prasado PD, Seth P, Rajan DP, Leibach FH, et al. Functional characterization and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/camitine transporter.J Pharmacol Exp Ther 290: 1482\u20131492, 1999.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR57", "first-page": "778", "volume": "291", "author": "R Ohashi", "year": "1999", "unstructured": "Ohashi R, Tamai I, Yabuuchi H, Nezu JI, Oku A, Sai Y, Shimane M, Tsuji A. Na(+)-dependent camitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.J Pharmacol Exp Ther 291: 778\u2013784, 1999.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR58", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1124/mol.59.2.358", "volume": "59", "author": "R Ohashi", "year": "2001", "unstructured": "Ohashi R, Tamai I, Nezu J, Nikaido H, Hashimoto N, Oku A, et al. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.Mol Pharmacol 59: 358\u2013366, 2001.", "journal-title": "Mol Pharmacol"}, {"key": "BF03206642_CR59", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/S0006-8993(02)04271-3", "volume": "968", "author": "A Friedlich", "year": "2003", "unstructured": "Friedlich A, Prasasd PD, Freyer D, Ganapathy V, Brust P. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.Brain Res 968: 69\u201379, 2003.", "journal-title": "Brain Res"}, {"key": "BF03206642_CR60", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1002/bdd.371", "volume": "24", "author": "A Inano", "year": "2003", "unstructured": "Inano A, Sai Y, Nikaido H, Hasimoto N, Asano M, Tsuji A. Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2. Biopharm Drug Dispos 24: 357\u2013365, 2003.", "journal-title": "Biopharm Drug Dispos"}, {"key": "BF03206642_CR61", "doi-asserted-by": "crossref", "first-page": "676", "DOI": "10.1248/bpb.17.676", "volume": "17", "author": "M Yamazaki", "year": "1994", "unstructured": "Yamazaki M, Fukuoka H, Nagata O, Kato H, Ito Y, Terasaki T, Tsuji A. Transport mechanism of an H1-antagonist at the blood-brain barrier: transport mechanism of mepyramine using carotid injection technique.Biol Pharm Bull 17: 676\u2013679, 1994.", "journal-title": "Biol Pharm Bull"}, {"key": "BF03206642_CR62", "doi-asserted-by": "crossref", "first-page": "975", "DOI": "10.1023/A:1018923017954", "volume": "11", "author": "M Yamazaki", "year": "1994", "unstructured": "Yamazaki M, Terasaki T, Yoshioka K, Nagata O, Kato H, Ito Y, et al. Carrier-mediated transport of H1-antagonist at the blood-brain barrier: mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures.Pharm Res 11: 975\u2013978, 1994.", "journal-title": "Pharm Res"}, {"key": "BF03206642_CR63", "doi-asserted-by": "crossref", "first-page": "1516", "DOI": "10.1023/A:1018980914687", "volume": "11", "author": "M Yamazaki", "year": "1994", "unstructured": "Yamazaki M, Terasaki T, Yoshioka K, Nagata O, Kato H, Ito Y, et al. Carrier-mediated transport of H1-antagonist at the blood-brain barrier: a common transport system of H1-antagonists and lipophilic basic drugs.Pharm Res 11: 1516\u20131518, 1994.", "journal-title": "Pharm Res"}, {"key": "BF03206642_CR64", "first-page": "866", "volume": "27", "author": "M Cvetkovic", "year": "1999", "unstructured": "Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.Drug Metab Dispos 27: 866\u2013871, 1999.", "journal-title": "Drug Metab Dispos"}, {"key": "BF03206642_CR65", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.1111/j.1365-2125.1988.tb05288.x", "volume": "26", "author": "J Vincent", "year": "1998", "unstructured": "Vincent J, Liminana R, Meredith PA, Reid JL. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.Br J Clin Pharmacol 26: 497\u2013502, 1998.", "journal-title": "Br J Clin Pharmacol"}, {"key": "BF03206642_CR66", "first-page": "55", "volume": "44", "author": "M Matsuda", "year": "1994", "unstructured": "Matsuda M, Sakashita M, Mizuki Y, Yamaguchi T, Fujii T, Sekine Y. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.Arzneim-Forsch/Drug Res 44: 55\u201359, 1994.", "journal-title": "Arzneim-Forsch/Drug Res"}, {"key": "BF03206642_CR67", "first-page": "59", "volume": "44", "author": "T Yamaguchi", "year": "1994", "unstructured": "Yamaguchi T, Hashizume T, Matsuda M, Sakashita M, Fujii T, Sekine Y, et al. Pharmacokinetics of the Hl-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects. Arzneimittelforschung 44: 59\u201364, 1994.", "journal-title": "Arzneimittelforschung"}, {"key": "BF03206642_CR68", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.3109/10611860008997914", "volume": "8", "author": "I Tamai", "year": "2000", "unstructured": "Tamai I, Kido Y, Yamashita J, Sai Y, Tsuji A. Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.J Drug Target 8: 383\u2013393, 2000.", "journal-title": "J Drug Target"}, {"key": "BF03206642_CR69", "first-page": "81", "volume": "282", "author": "J Huwyler", "year": "1997", "unstructured": "Huwyler J, Flicker G, Torok M, Schneider M, Drewe J. Transport of clonidine across cultured brain microvessel endothelial cells.J Pharmacol Exp Ther 282: 81\u201385, 1997.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR70", "first-page": "1084", "volume": "289", "author": "TK Henthom", "year": "1999", "unstructured": "Henthom TK, Liu Y, Mahapatro M, Ng KY. Active transport of fentanyl by the blood-brain barrier.J Pharmacol Exp Ther 289: 1084\u20131089, 1999.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR71", "doi-asserted-by": "crossref", "first-page": "1351", "DOI": "10.1248/bpb.25.1351", "volume": "25", "author": "T Suzuki", "year": "2002", "unstructured": "Suzuki T, Moriki Y, Goto H, Tomono K, Hanano M, Watanabe J. Investigation on the influx transport mechanism of pentazocine at the blood-brain barrier in rats using the carotid injection technique.Biol Pharm Bull 25: 1351\u20131355, 2002.", "journal-title": "Biol Pharm Bull"}, {"key": "BF03206642_CR72", "doi-asserted-by": "crossref", "first-page": "932", "DOI": "10.1248/bpb.27.932", "volume": "27", "author": "Y Moriki", "year": "2004", "unstructured": "Moriki Y, Suzuki T, Fukami T, Hanano M, Tomono K, Watanabe J. Involvement of P-glycoprotein in blood-brain barrier transport of pentazocine in rats using brain uptake index method.Biol Pharm Bull 27: 932\u2013935, 2004.", "journal-title": "Biol Pharm Bull"}, {"key": "BF03206642_CR73", "doi-asserted-by": "crossref", "first-page": "1289", "DOI": "10.1016/0196-9781(92)90037-4", "volume": "13", "author": "WA Banks", "year": "1992", "unstructured": "Banks WA, Audus K, Davis TP. Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs.Peptides 13: 1289\u20131294, 1992.", "journal-title": "Peptides"}, {"key": "BF03206642_CR74", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1111/j.2042-7158.1996.tb07112.x", "volume": "48", "author": "DJ Begley", "year": "1996", "unstructured": "Begley DJ. The blood-brain barrier: principle for targeting peptides and drugs to the central nervous system.J Pharm Pharmacol 48: 136\u2013146, 1996.", "journal-title": "J Pharm Pharmacol"}, {"key": "BF03206642_CR75", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1111/j.1471-4159.1988.tb04864.x", "volume": "51", "author": "BV Zlokovic", "year": "1988", "unstructured": "Zlokovic, BV, Lipovac MN, Begley DJ, Davson H, Rakic L. Slow penetration of thyrotropine-releasing hormone across the blood-brain barrier of an in situ perfused guinea pig brain.J Neurochem 51: 252\u2013257, 1988.", "journal-title": "J Neurochem"}, {"key": "BF03206642_CR76", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1016/0005-2736(90)90097-8", "volume": "1025", "author": "BV Zlokovic", "year": "1990", "unstructured": "Zlokovic BV, Hyman S, McComb JG, Lipovac MN, Tang G, Davson H. Kinetics of arginine-vasopressin uptake at the blood-brain barrier.Biochim Biophys Acta 1025: 191\u2013198, 1990.", "journal-title": "Biochim Biophys Acta"}, {"key": "BF03206642_CR77", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1016/0361-9230(87)90048-7", "volume": "19", "author": "CM Barrera", "year": "1987", "unstructured": "Barrera CM, Kastin AJ, Banks WA. D-[Ala1]-peptide T-amide is transported from blood to brain by saturable system.Brain Res Bull 19: 629\u2013633, 1987.", "journal-title": "Brain Res Bull"}, {"key": "BF03206642_CR78", "doi-asserted-by": "crossref", "first-page": "262", "DOI": "10.1007/BF00177572", "volume": "96", "author": "JF Wilson", "year": "1988", "unstructured": "Wilson JF. Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive \u03b1-melanotropin.Psychopharmacol 96: 262\u2013266, 1988.", "journal-title": "Psychopharmacol"}, {"key": "BF03206642_CR79", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/0006-8993(84)91088-6", "volume": "301", "author": "WA Banks", "year": "1984", "unstructured": "Banks WA, Kastin AJ, Coy DH. Evidence that125I-N-Tyr-\u03b4 sleeping peptide crosses the blood-brain barrier by a noncompetitive mechanism.Brain Res 301: 201\u2013207, 1984.", "journal-title": "Brain Res"}, {"key": "BF03206642_CR80", "first-page": "73", "volume": "294", "author": "B Gao", "year": "2000", "unstructured": "Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.J Pharmacol Exp Ther 294: 73\u201379, 2000.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR81", "first-page": "E1", "volume": "259", "author": "R Kannan", "year": "1990", "unstructured": "Kannan R, Kuhlenkamp JF, Jeandidier E, Trinh H, Ookhtens M, Kaplowitz N. Evidence for carrier-mediated transport for glutathi-one across the blood-brain barrier in the rat.Am J Physiol (Lond) 259: E1-E10, 1990.", "journal-title": "Am J Physiol (Lond)"}, {"key": "BF03206642_CR82", "first-page": "964", "volume": "263", "author": "R Kannan", "year": "1992", "unstructured": "Kannan R, Kuhlenkamp JF, Ookhtens M, Kaplowitz N. Transport of glutathione at the blood-brain barrier of the rat: inhibition by glutathione analogues and age-dependence.J Pharmacol Exp Ther 263: 964\u2013970, 1992.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR83", "doi-asserted-by": "crossref", "first-page": "402", "DOI": "10.1006/bbrc.1994.1715", "volume": "201", "author": "BV Zlokovic", "year": "1994", "unstructured": "Zlokovic BV, Mackic JB, McComb JG, Weiss MH, Kaplowitz N, Kannan R. Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain.Biochem Biophys Res Commun 201: 402\u2013408, 1994.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "BF03206642_CR84", "doi-asserted-by": "crossref", "first-page": "9754", "DOI": "10.1074/jbc.271.16.9754", "volume": "271", "author": "R Kannan", "year": "1996", "unstructured": "Kannan R, Yi JR, Tang D, Li Y, Zlokovic BV, Kaplowitz N. Evidence for the existence of a sodium-dependent glutathione (GSH) transporter. Expression of bovine brain capillary mRNA and size fractions inXenopus laevis oocytes and dissociation from \u03b3-glutamyltranspeptidase and facilitative GSH transporters.J Biol Chem 271: 9754\u20139758, 1996.", "journal-title": "J Biol Chem"}, {"key": "BF03206642_CR85", "doi-asserted-by": "crossref", "first-page": "390", "DOI": "10.1046/j.1471-4159.1999.0730390.x", "volume": "73", "author": "R Kannan", "year": "1999", "unstructured": "Kannan R, Mittur A, Bao Y, Tsuruo T, Kaplowitz N. GSH transport in immortalized mouse brain endothelial cells: evidence for apical localization of a sodium-dependent GSH transporter.J Neurochem 73: 390\u2013399, 1999.", "journal-title": "J Neurochem"}, {"key": "BF03206642_CR86", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1124/jpet.102.046243", "volume": "305", "author": "H Toyobuku", "year": "2003", "unstructured": "Toyobuku H, Sai Y, Kagami T, Tamai I, Tsuji A. Delivery of peptide drugs to the brain by adenovirus-mediated heterologous expression of human oligopeptide transporter at the blood-brain barrier.J Pharmacol Exp Ther 305: 40\u201347, 2003.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF03206642_CR87", "doi-asserted-by": "crossref", "first-page": "174", "DOI": "10.1016/S0167-4889(97)00096-7", "volume": "1359", "author": "R Schlapbach", "year": "1997", "unstructured": "Schlapbach R, Fontana, A. Differential activity of bc1\u20132 and ICE enzyme family protease inhibitors on Fas and puromycin-induced apoptosis of glioma cells.Biochim Biophys Acta 1359: 174\u2013180, 1997.", "journal-title": "Biochim Biophys Acta"}], "container-title": ["Neurotherapeutics"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/BF03206642", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T16:41:33Z", "timestamp": 1572885693000}, "score": 86.01584, "issued": {"date-parts": [[2005, 1]]}, "references-count": 87, "journal-issue": {"published-print": {"date-parts": [[2005, 1]]}, "issue": "1"}, "alternative-id": ["BF03206642"], "URL": "http://dx.doi.org/10.1007/bf03206642", "relation": {"cites": []}, "ISSN": ["1933-7213", "1878-7479"], "issn-type": [{"value": "1933-7213", "type": "print"}, {"value": "1878-7479", "type": "electronic"}], "subject": ["Pharmacology (medical)", "Pharmacology", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:26:24Z", "timestamp": 1574108784587}, "reference-count": 65, "publisher": "Elsevier BV", "issue": "2-3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 4, 1]], "date-time": "1999-04-01T00:00:00Z", "timestamp": 922924800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Advanced Drug Delivery Reviews"], "published-print": {"date-parts": [[1999, 4]]}, "DOI": "10.1016/s0169-409x(98)00084-2", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T02:54:20Z", "timestamp": 1027652060000}, "page": "277-290", "source": "Crossref", "is-referenced-by-count": 102, "title": ["Carrier-mediated or specialized transport of drugs across the blood\u2013brain barrier"], "prefix": "10.1016", "volume": "36", "author": [{"given": "Akira", "family": "Tsuji", "sequence": "first", "affiliation": []}, {"given": "Ikumi", "family": "Tamai", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Advanced Drug Delivery Reviews"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0169409X98000842?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0169409X98000842?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 14]], "date-time": "2019-04-14T03:58:26Z", "timestamp": 1555214306000}, "score": 54.707703, "issued": {"date-parts": [[1999, 4]]}, "references-count": 65, "journal-issue": {"published-print": {"date-parts": [[1999, 4]]}, "issue": "2-3"}, "alternative-id": ["S0169409X98000842"], "URL": "http://dx.doi.org/10.1016/s0169-409x(98)00084-2", "ISSN": ["0169-409X"], "issn-type": [{"value": "0169-409X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:26:43Z", "timestamp": 1574123203281}, "reference-count": 20, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Therapeutic Drug Monitoring"], "published-print": {"date-parts": [[1998, 10]]}, "DOI": "10.1097/00007691-199810000-00024", "type": "journal-article", "created": {"date-parts": [[2003, 4, 25]], "date-time": "2003-04-25T13:01:50Z", "timestamp": 1051275710000}, "page": "588-590", "source": "Crossref", "is-referenced-by-count": 42, "title": ["P-Glycoprotein-Mediated Efflux Transport of Anticancer Drugs at the Blood-Brain Barrier"], "prefix": "10.1097", "volume": "20", "author": [{"given": "Akira", "family": "Tsuji", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Therapeutic Drug Monitoring"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T08:01:59Z", "timestamp": 1518163319000}, "score": 43.491966, "subtitle": [""], "issued": {"date-parts": [[1998, 10]]}, "references-count": 20, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1097/00007691-199810000-00024", "ISSN": ["0163-4356"], "issn-type": [{"value": "0163-4356", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:46:26Z", "timestamp": 1574145986628}, "reference-count": 37, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 2, 1]], "date-time": "1994-02-01T00:00:00Z", "timestamp": 760060800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Controlled Release"], "published-print": {"date-parts": [[1994, 2]]}, "DOI": "10.1016/0168-3659(94)90132-5", "type": "journal-article", "created": {"date-parts": [[2002, 12, 14]], "date-time": "2002-12-14T12:32:55Z", "timestamp": 1039869175000}, "page": "163-169", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Drug delivery to the brain utilizing blood-brain barrier transport systems"], "prefix": "10.1016", "volume": "29", "author": [{"given": "Tetsuya", "family": "Terasaki", "sequence": "first", "affiliation": []}, {"given": "Akira", "family": "Tsuji", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Controlled Release"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0168365994901325?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0168365994901325?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 1]], "date-time": "2019-04-01T09:54:00Z", "timestamp": 1554112440000}, "score": 40.393135, "issued": {"date-parts": [[1994, 2]]}, "references-count": 37, "journal-issue": {"published-print": {"date-parts": [[1994, 2]]}, "issue": "1-2"}, "alternative-id": ["0168365994901325"], "URL": "http://dx.doi.org/10.1016/0168-3659(94)90132-5", "ISSN": ["0168-3659"], "issn-type": [{"value": "0168-3659", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T17:23:59Z", "timestamp": 1576776239600}, "edition-number": "1", "reference-count": 0, "publisher": "Cambridge University Press", "isbn-type": [{"value": "9780521034272", "type": "print"}, {"value": "9780511570216", "type": "electronic"}], "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2009, 12, 10]], "date-time": "2009-12-10T00:00:00Z", "timestamp": 1260403200000}, "delay-in-days": 4122, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1998, 8, 28]]}, "DOI": "10.1017/cbo9780511570216.026", "type": "book-chapter", "created": {"date-parts": [[2009, 12, 24]], "date-time": "2009-12-24T13:25:55Z", "timestamp": 1261661155000}, "page": "238-248", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Blood\u2013brain barrier transport of drugs"], "prefix": "10.1017", "author": [{"given": "Akira", "family": "Tsuji", "sequence": "first", "affiliation": []}, {"given": "Ikumi", "family": "Tamai", "sequence": "additional", "affiliation": []}], "member": "56", "container-title": ["Introduction to the Blood-Brain Barrier"], "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/411260C459F59FF7CD2531E646D2760F", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T19:58:31Z", "timestamp": 1575316711000}, "score": 40.25483, "issued": {"date-parts": [[1998, 8, 28]]}, "ISBN": ["9780521581240", "9780511570216", "9780521034272"], "references-count": 0, "URL": "http://dx.doi.org/10.1017/cbo9780511570216.026"}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T20:28:15Z", "timestamp": 1575059295013}, "reference-count": 24, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 11, 1]], "date-time": "1999-11-01T00:00:00Z", "timestamp": 941414400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Controlled Release"], "published-print": {"date-parts": [[1999, 11]]}, "DOI": "10.1016/s0168-3659(99)00043-7", "type": "journal-article", "created": {"date-parts": [[2002, 10, 11]], "date-time": "2002-10-11T00:53:51Z", "timestamp": 1034297631000}, "page": "239-244", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Tissue selective drug delivery utilizing carrier-mediated transport systems"], "prefix": "10.1016", "volume": "62", "author": [{"given": "Akira", "family": "Tsuji", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Controlled Release"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0168365999000437?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0168365999000437?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T11:24:50Z", "timestamp": 1556796290000}, "score": 39.963787, "issued": {"date-parts": [[1999, 11]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[1999, 11]]}, "issue": "1-2"}, "alternative-id": ["S0168365999000437"], "URL": "http://dx.doi.org/10.1016/s0168-3659(99)00043-7", "ISSN": ["0168-3659"], "issn-type": [{"value": "0168-3659", "type": "print"}], "subject": ["Pharmaceutical Science"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:00:23Z", "timestamp": 1574269223940}, "reference-count": 47, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 2, 1]], "date-time": "2007-02-01T00:00:00Z", "timestamp": 1170288000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Surgical Neurology"], "published-print": {"date-parts": [[2007, 2]]}, "DOI": "10.1016/j.surneu.2006.08.033", "type": "journal-article", "created": {"date-parts": [[2007, 1, 24]], "date-time": "2007-01-24T12:12:10Z", "timestamp": 1169640730000}, "page": "113-116", "source": "Crossref", "is-referenced-by-count": 71, "title": ["Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier"], "prefix": "10.1016", "volume": "67", "author": [{"given": "Gabriel A.", "family": "Silva", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Surgical Neurology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0090301906006963?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0090301906006963?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 9]], "date-time": "2019-01-09T18:27:42Z", "timestamp": 1547058462000}, "score": 38.516872, "issued": {"date-parts": [[2007, 2]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2007, 2]]}, "issue": "2"}, "alternative-id": ["S0090301906006963"], "URL": "http://dx.doi.org/10.1016/j.surneu.2006.08.033", "ISSN": ["0090-3019"], "issn-type": [{"value": "0090-3019", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T20:01:12Z", "timestamp": 1574366472493}, "reference-count": 30, "publisher": "Elsevier BV", "issue": "7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 7, 1]], "date-time": "2008-07-01T00:00:00Z", "timestamp": 1214870400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2016, 10, 7]], "date-time": "2016-10-07T00:00:00Z", "timestamp": 1475798400000}, "delay-in-days": 3020, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Therapy"], "published-print": {"date-parts": [[2008, 7]]}, "DOI": "10.1038/mt.2008.84", "type": "journal-article", "created": {"date-parts": [[2008, 4, 29]], "date-time": "2008-04-29T11:23:17Z", "timestamp": 1209468197000}, "page": "1261-1266", "source": "Crossref", "is-referenced-by-count": 52, "title": ["Mannose 6-Phosphate Receptor\u2013mediated Transport of Sulfamidase Across the Blood\u2013brain Barrier in the Newborn Mouse"], "prefix": "10.1016", "volume": "16", "author": [{"given": "Akihiko", "family": "Urayama", "sequence": "first", "affiliation": []}, {"given": "Jeffrey H", "family": "Grubb", "sequence": "additional", "affiliation": []}, {"given": "William S", "family": "Sly", "sequence": "additional", "affiliation": []}, {"given": "William A", "family": "Banks", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Molecular Therapy"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1525001616324662?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1525001616324662?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 29]], "date-time": "2018-12-29T12:26:53Z", "timestamp": 1546086413000}, "score": 38.497475, "issued": {"date-parts": [[2008, 7]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2008, 7]]}, "issue": "7"}, "alternative-id": ["S1525001616324662"], "URL": "http://dx.doi.org/10.1038/mt.2008.84", "ISSN": ["1525-0016"], "issn-type": [{"value": "1525-0016", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T11:27:50Z", "timestamp": 1575286070695}, "reference-count": 43, "publisher": "American Chemical Society (ACS)", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol. Pharmaceutics"], "published-print": {"date-parts": [[2013, 12, 2]]}, "DOI": "10.1021/mp400316e", "type": "journal-article", "created": {"date-parts": [[2013, 10, 7]], "date-time": "2013-10-07T17:05:53Z", "timestamp": 1381165553000}, "page": "4491-4498", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Memantine Transport across the Mouse Blood\u2013Brain Barrier Is Mediated by a Cationic Influx H+Antiporter"], "prefix": "10.1021", "volume": "10", "author": [{"given": "Dharmini C.", "family": "Mehta", "sequence": "first", "affiliation": [{"name": "Drug Delivery, Disposition and Dynamics, and \u2021Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia"}]}, {"given": "Jennifer L.", "family": "Short", "sequence": "additional", "affiliation": [{"name": "Drug Delivery, Disposition and Dynamics, and \u2021Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia"}]}, {"given": "Joseph A.", "family": "Nicolazzo", "sequence": "additional", "affiliation": [{"name": "Drug Delivery, Disposition and Dynamics, and \u2021Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia"}]}], "member": "316", "published-online": {"date-parts": [[2013, 10, 29]]}, "container-title": ["Molecular Pharmaceutics"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/mp400316e", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 9]], "date-time": "2019-10-09T08:04:09Z", "timestamp": 1570608249000}, "score": 37.29747, "issued": {"date-parts": [[2013, 10, 29]]}, "references-count": 43, "journal-issue": {"published-online": {"date-parts": [[2013, 11, 8]]}, "published-print": {"date-parts": [[2013, 12, 2]]}, "issue": "12"}, "alternative-id": ["10.1021/mp400316e"], "URL": "http://dx.doi.org/10.1021/mp400316e", "ISSN": ["1543-8384", "1543-8392"], "issn-type": [{"value": "1543-8384", "type": "print"}, {"value": "1543-8392", "type": "electronic"}], "subject": ["Molecular Medicine", "Drug Discovery", "Pharmaceutical Science"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T16:56:43Z", "timestamp": 1575219403278}, "reference-count": 13, "publisher": "American Chemical Society (ACS)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol. Pharmaceutics"], "published-print": {"date-parts": [[2013, 5, 6]]}, "DOI": "10.1021/mp400170b", "type": "journal-article", "created": {"date-parts": [[2013, 5, 6]], "date-time": "2013-05-06T04:26:27Z", "timestamp": 1367814387000}, "page": "1471-1472", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Drug Delivery across the Blood\u2013Brain Barrier"], "prefix": "10.1021", "volume": "10", "author": [{"given": "Leslie A.", "family": "Khawli", "sequence": "first", "affiliation": [{"name": "Genentech Research &amp; Early Development, One DNA\rWay, South San Francisco, California 94080, United States"}]}, {"given": "Saileta", "family": "Prabhu", "sequence": "additional", "affiliation": [{"name": "Genentech Research &amp; Early Development, One DNA\rWay, South San Francisco, California 94080, United States"}]}], "member": "316", "published-online": {"date-parts": [[2013, 5, 6]]}, "container-title": ["Molecular Pharmaceutics"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/mp400170b", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T13:07:08Z", "timestamp": 1569848828000}, "score": 37.258858, "issued": {"date-parts": [[2013, 5, 6]]}, "references-count": 13, "journal-issue": {"published-online": {"date-parts": [[2013, 4, 23]]}, "published-print": {"date-parts": [[2013, 5, 6]]}, "issue": "5"}, "alternative-id": ["10.1021/mp400170b"], "URL": "http://dx.doi.org/10.1021/mp400170b", "ISSN": ["1543-8384", "1543-8392"], "issn-type": [{"value": "1543-8384", "type": "print"}, {"value": "1543-8392", "type": "electronic"}], "subject": ["Molecular Medicine", "Drug Discovery", "Pharmaceutical Science"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:06:24Z", "timestamp": 1574294784165}, "reference-count": 64, "publisher": "Elsevier", "isbn-type": [{"value": "9780126390117", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 1, 1]], "date-time": "2004-01-01T00:00:00Z", "timestamp": 1072915200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2004]]}, "DOI": "10.1016/b978-012639011-7/50014-0", "type": "book-chapter", "created": {"date-parts": [[2007, 5, 24]], "date-time": "2007-05-24T07:35:24Z", "timestamp": 1179992124000}, "page": "99-105", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Mechanisms of Antisense Transport across the Blood\u2013Brain Barrier"], "prefix": "10.1016", "author": [{"given": "WILLIAM A.", "family": "BANKS", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Blood-Spinal Cord and Brain Barriers in Health and Disease"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9780126390117500140?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9780126390117500140?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 7]], "date-time": "2019-01-07T07:24:38Z", "timestamp": 1546845878000}, "score": 37.13103, "issued": {"date-parts": [[2004]]}, "ISBN": ["9780126390117"], "references-count": 64, "URL": "http://dx.doi.org/10.1016/b978-012639011-7/50014-0"}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:32:36Z", "timestamp": 1574109156008}, "reference-count": 22, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 6, 1]], "date-time": "2002-06-01T00:00:00Z", "timestamp": 1022889600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Brain Research"], "published-print": {"date-parts": [[2002, 6]]}, "DOI": "10.1016/s0006-8993(02)02654-9", "type": "journal-article", "created": {"date-parts": [[2002, 10, 11]], "date-time": "2002-10-11T03:00:12Z", "timestamp": 1034305212000}, "page": "46-50", "source": "Crossref", "is-referenced-by-count": 14, "title": ["S-adenosylmethionine is substrate for carrier mediated transport at the blood\u2013brain barrier in vitro"], "prefix": "10.1016", "volume": "942", "author": [{"given": "M.", "family": "Chishty", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Reichel", "sequence": "additional", "affiliation": []}, {"given": "N.J.", "family": "Abbott", "sequence": "additional", "affiliation": []}, {"given": "D.J.", "family": "Begley", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Brain Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0006899302026549?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0006899302026549?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 13]], "date-time": "2019-04-13T18:54:08Z", "timestamp": 1555181648000}, "score": 37.120163, "issued": {"date-parts": [[2002, 6]]}, "references-count": 22, "journal-issue": {"published-print": {"date-parts": [[2002, 6]]}, "issue": "1-2"}, "alternative-id": ["S0006899302026549"], "URL": "http://dx.doi.org/10.1016/s0006-8993(02)02654-9", "ISSN": ["0006-8993"], "issn-type": [{"value": "0006-8993", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 16]], "date-time": "2019-12-16T21:36:01Z", "timestamp": 1576532161422}, "reference-count": 152, "publisher": "Elsevier BV", "issue": "11", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2000, 11, 1]], "date-time": "2000-11-01T00:00:00Z", "timestamp": 973036800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Pharmaceutical Sciences"], "published-print": {"date-parts": [[2000, 11]]}, "DOI": "10.1002/1520-6017(200011)89:11<1371::aid-jps1>3.0.co;2-d", "type": "journal-article", "created": {"date-parts": [[2003, 3, 28]], "date-time": "2003-03-28T21:55:08Z", "timestamp": 1048888508000}, "page": "1371-1388", "source": "Crossref", "is-referenced-by-count": 217, "title": ["Transporter-Mediated Permeation of Drugs Across the Blood\u2013Brain Barrier"], "prefix": "10.1016", "volume": "89", "author": [{"given": "Ikumi", "family": "Tamai", "sequence": "first", "affiliation": []}, {"given": "Akira", "family": "Tsuji", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Pharmaceutical Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022354916306797?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022354916306797?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 12, 15]], "date-time": "2019-12-15T05:02:41Z", "timestamp": 1576386161000}, "score": 36.490913, "issued": {"date-parts": [[2000, 11]]}, "references-count": 152, "journal-issue": {"published-print": {"date-parts": [[2000, 11]]}, "issue": "11"}, "alternative-id": ["S0022354916306797"], "URL": "http://dx.doi.org/10.1002/1520-6017(200011)89:11<1371::aid-jps1>3.0.co;2-d", "ISSN": ["0022-3549"], "issn-type": [{"value": "0022-3549", "type": "print"}], "subject": ["Pharmaceutical Science"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:59:18Z", "timestamp": 1574099958968}, "reference-count": 123, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 6, 1]], "date-time": "1996-06-01T00:00:00Z", "timestamp": 833587200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Advanced Drug Delivery Reviews"], "published-print": {"date-parts": [[1996, 6]]}, "DOI": "10.1016/0169-409x(96)00011-7", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T17:25:52Z", "timestamp": 1027617952000}, "page": "401-424", "source": "Crossref", "is-referenced-by-count": 72, "title": ["Drug delivery through the blood-brain barrier"], "prefix": "10.1016", "volume": "19", "author": [{"given": "Ikumi", "family": "Tamai", "sequence": "first", "affiliation": []}, {"given": "Akira", "family": "Tsuji", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Advanced Drug Delivery Reviews"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0169409X96000117?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0169409X96000117?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 24]], "date-time": "2019-04-24T23:25:07Z", "timestamp": 1556148307000}, "score": 36.48382, "issued": {"date-parts": [[1996, 6]]}, "references-count": 123, "journal-issue": {"published-print": {"date-parts": [[1996, 6]]}, "issue": "3"}, "alternative-id": ["0169409X96000117"], "URL": "http://dx.doi.org/10.1016/0169-409x(96)00011-7", "ISSN": ["0169-409X"], "issn-type": [{"value": "0169-409X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:15:35Z", "timestamp": 1574414135777}, "reference-count": 92, "publisher": "CRC Press", "isbn-type": [{"value": "9780824703943", "type": "print"}, {"value": "9780824741990", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2000, 5, 16]]}, "DOI": "10.1201/9780824741990.ch8", "type": "book-chapter", "created": {"date-parts": [[2010, 2, 23]], "date-time": "2010-02-23T23:59:46Z", "timestamp": 1266969586000}, "source": "Crossref", "is-referenced-by-count": 3, "title": ["Specific Mechanisms for Transporting Drugs Into Brain"], "prefix": "10.1201", "author": [{"given": "Akira", "family": "Tsuji", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 12]]}, "reference": [{"key": "p_1", "author": "Cornford EM", "volume": "7", "first-page": "219", "year": "1985", "journal-title": "Mol Physiol"}, {"key": "p_2", "DOI": "10.1021/jm00180a022", "doi-asserted-by": "publisher"}, {"key": "p_3", "author": "Pardridge WM", "volume": "253", "first-page": "884", "year": "1990", "journal-title": "J Pharmacol Exp Ther"}, {"key": "p_4", "DOI": "10.1016/0169-409X(95)00003-P", "doi-asserted-by": "publisher"}, {"key": "p_5", "DOI": "10.1023/A:1016254514167", "doi-asserted-by": "publisher"}, {"key": "p_6", "DOI": "10.1023/A:1015884603456", "doi-asserted-by": "publisher"}, {"key": "p_7", "DOI": "10.1016/0169-409X(96)00011-7", "doi-asserted-by": "publisher"}, {"key": "p_8", "DOI": "10.1016/S0169-409X(97)00504-8", "doi-asserted-by": "publisher"}, {"key": "p_9", "DOI": "10.1016/S0169-409X(98)00085-4", "doi-asserted-by": "publisher"}, {"key": "p_10", "DOI": "10.1111/j.2042-7158.1996.tb07112.x", "doi-asserted-by": "publisher"}, {"key": "p_11", "DOI": "10.1016/0024-3205(92)90537-Y", "doi-asserted-by": "publisher"}, {"key": "p_12", "DOI": "10.1016/0006-2952(93)90677-O", "doi-asserted-by": "publisher"}, {"key": "p_13", "DOI": "10.1016/0006-2952(94)90601-7", "doi-asserted-by": "publisher"}, {"key": "p_14", "DOI": "10.1016/0006-2952(95)00082-B", "doi-asserted-by": "publisher"}, {"key": "p_15", "author": "Tatsuta T", "volume": "267", "first-page": "20383", "year": "1992", "journal-title": "J Biol Chem"}, {"key": "p_16", "DOI": "10.1016/0165-5728(92)90181-J", "doi-asserted-by": "publisher"}, {"key": "p_17", "author": "Hegmann EJ", "volume": "52", "first-page": "6969", "year": "1992", "journal-title": "Cancer Res"}, {"key": "p_18", "DOI": "10.1006/bbrc.1995.1872", "doi-asserted-by": "publisher"}, {"key": "p_19", "DOI": "10.1023/A:1011988024295", "doi-asserted-by": "publisher"}, {"key": "p_20", "DOI": "10.1016/0092-8674(94)90212-7", "doi-asserted-by": "publisher"}, {"key": "p_21", "DOI": "10.1073/pnas.94.8.4028", "doi-asserted-by": "publisher"}, {"key": "p_22", "DOI": "10.1172/JCI118214", "doi-asserted-by": "publisher"}, {"key": "p_23", "DOI": "10.1111/j.1476-5381.1996.tb15775.x", "doi-asserted-by": "publisher"}, {"key": "p_24", "DOI": "10.1172/JCI118699", "doi-asserted-by": "publisher"}, {"key": "p_25", "DOI": "10.1172/JCI119784", "doi-asserted-by": "publisher"}, {"key": "p_26", "DOI": "10.1172/JCI1269", "doi-asserted-by": "publisher"}, {"key": "p_27", "DOI": "10.1021/js9701364", "doi-asserted-by": "publisher"}, {"key": "p_28", "DOI": "10.1006/abbi.1997.0537", "doi-asserted-by": "publisher"}, {"key": "p_29", "DOI": "10.1203/00006450-199811000-00020", "doi-asserted-by": "publisher"}, {"key": "p_30", "DOI": "10.1007/BF00229652", "doi-asserted-by": "publisher"}, {"key": "p_31", "DOI": "10.1097/00007691-199810000-00024", "doi-asserted-by": "publisher"}, {"key": "p_32", "DOI": "10.1016/0006-8993(70)90123-X", "doi-asserted-by": "publisher"}, {"key": "p_33", "DOI": "10.1007/s002800050515", "doi-asserted-by": "publisher"}, {"key": "p_34", "DOI": "10.1046/j.1471-4159.1996.67041688.x", "doi-asserted-by": "publisher"}, {"key": "p_35", "DOI": "10.1016/S0024-3205(97)00370-6", "doi-asserted-by": "publisher"}, {"key": "p_36", "author": "Terasaki T", "volume": "258", "first-page": "932", "year": "1991", "journal-title": "J Pharmacol Exp Ther"}, {"key": "p_37", "DOI": "10.1111/j.2042-7158.1991.tb06660.x", "doi-asserted-by": "publisher"}, {"key": "p_38", "author": "Tsuji A", "volume": "267", "first-page": "1085", "year": "1993", "journal-title": "J Pharmacol Exp Ther"}, {"key": "p_39", "DOI": "10.1023/A:1018975928974", "doi-asserted-by": "publisher"}, {"key": "p_40", "DOI": "10.1006/bbrc.1995.2786", "doi-asserted-by": "publisher"}, {"key": "p_41", "author": "Gerhart DZ", "volume": "273", "first-page": "E207", "year": "1997", "journal-title": "Am J Physiol"}, {"key": "p_42", "DOI": "10.1046/j.1471-4159.1996.66020756.x", "doi-asserted-by": "publisher"}, {"key": "p_43", "author": "Adkison KD", "volume": "276", "first-page": "1189", "year": "1996", "journal-title": "J Pharmacol Exp Therap"}, {"key": "p_44", "DOI": "10.1074/jbc.272.30.18526", "doi-asserted-by": "publisher"}, {"key": "p_45", "DOI": "10.1016/S0014-5793(98)00585-7", "doi-asserted-by": "publisher"}, {"key": "p_46", "DOI": "10.1016/0301-0082(95)00046-1", "doi-asserted-by": "publisher"}, {"key": "p_47", "DOI": "10.1248/bpb1978.13.10", "doi-asserted-by": "publisher"}, {"key": "p_48", "DOI": "10.1248/bpb1978.13.353", "doi-asserted-by": "publisher"}, {"key": "p_49", "author": "Yamazaki M", "volume": "17", "first-page": "676", "year": "1994", "journal-title": "J Pharmacobio-Dyn"}, {"key": "p_50", "DOI": "10.1023/A:1018923017954", "doi-asserted-by": "publisher"}, {"key": "p_51", "DOI": "10.1023/A:1018980914687", "doi-asserted-by": "publisher"}, {"key": "p_52", "DOI": "10.1023/A:1022482604276", "doi-asserted-by": "publisher"}, {"key": "p_53", "DOI": "10.1097/00004647-199801000-00004", "doi-asserted-by": "publisher"}, {"key": "p_54", "DOI": "10.1016/0006-2952(95)02046-2", "doi-asserted-by": "publisher"}, {"key": "p_55", "DOI": "10.1006/bbrc.1997.7779", "doi-asserted-by": "publisher"}, {"key": "p_56", "DOI": "10.1074/jbc.273.32.20378", "doi-asserted-by": "publisher"}, {"key": "p_57", "DOI": "10.1073/pnas.91.15.7114", "doi-asserted-by": "publisher"}, {"key": "p_58", "DOI": "10.1046/j.1471-4159.1998.70020772.x", "doi-asserted-by": "publisher"}, {"key": "p_59", "author": "Pardridge WM", "year": "1991", "volume-title": "Peptide Drug Delivery to the Brain"}, {"key": "p_60", "author": "Pardridge WM", "first-page": "265", "year": "1995", "volume-title": "Peptide-Based Drug Design."}, {"key": "p_61", "author": "Terasaki T", "first-page": "297", "year": "1995", "volume-title": "Peptide-Based Drug Design."}, {"key": "p_62", "DOI": "10.1023/A:1016086003070", "doi-asserted-by": "publisher"}, {"key": "p_63", "DOI": "10.1074/jbc.272.17.11408", "doi-asserted-by": "publisher"}, {"key": "p_64", "DOI": "10.1021/js980062b", "doi-asserted-by": "publisher"}, {"key": "p_65", "DOI": "10.1172/JCI114666", "doi-asserted-by": "publisher"}, {"key": "p_66", "DOI": "10.1074/jbc.271.16.9754", "doi-asserted-by": "publisher"}, {"key": "p_67", "DOI": "10.1023/A:1015848531603", "doi-asserted-by": "publisher"}, {"key": "p_68", "author": "Shimura T", "volume": "258", "first-page": "459", "year": "1991", "journal-title": "J Pharmacol Exp Ther"}, {"key": "p_69", "DOI": "10.1111/j.2042-7158.1992.tb05469.x", "doi-asserted-by": "publisher"}, {"key": "p_70", "author": "Terasaki T", "volume": "251", "first-page": "351", "year": "1989", "journal-title": "J Pharmacol Exp Ther"}, {"key": "p_71", "DOI": "10.1023/A:1015882924470", "doi-asserted-by": "publisher"}, {"key": "p_72", "author": "Tamai I", "volume": "280", "first-page": "410", "year": "1997", "journal-title": "J Pharmacol Exp Ther"}, {"key": "p_73", "DOI": "10.1246/bcsj.71.699", "doi-asserted-by": "publisher"}, {"key": "p_74", "author": "Kumagai AK", "volume": "262", "first-page": "15214", "year": "1987", "journal-title": "J Biol Chem"}, {"key": "p_75", "author": "Pardridge WM", "volume": "251", "first-page": "521", "year": "1989", "journal-title": "J Pharmacol Exp Ther"}, {"key": "p_76", "DOI": "10.1016/0014-5793(91)80996-G", "doi-asserted-by": "publisher"}, {"key": "p_77", "DOI": "10.1073/pnas.92.22.10227", "doi-asserted-by": "publisher"}, {"key": "p_78", "DOI": "10.1016/S0196-9781(97)00198-8", "doi-asserted-by": "publisher"}, {"key": "p_79", "DOI": "10.1023/A:1018942728317", "doi-asserted-by": "publisher"}, {"key": "p_80", "DOI": "10.1006/bbrc.1997.8132", "doi-asserted-by": "publisher"}, {"key": "p_81", "author": "Kurihara H", "volume": "285", "first-page": "1260", "year": "1998", "journal-title": "J Pharmacol Exp Ther"}, {"key": "p_82", "DOI": "10.1046/j.1471-4159.1998.71020705.x", "doi-asserted-by": "publisher"}, {"key": "p_83", "author": "Martins JM", "volume": "272", "first-page": "E312", "year": "1997", "journal-title": "Am J Physiol"}, {"key": "p_84", "author": "Kitazawa T", "volume": "286", "first-page": "890", "year": "1998", "journal-title": "J Pharmacol Exp Ther"}, {"key": "p_85", "author": "Deguchi Y", "volume": "280", "first-page": "551", "year": "1997", "journal-title": "J Pharmacol Exp Ther"}, {"key": "p_86", "DOI": "10.1073/pnas.95.7.3990", "doi-asserted-by": "publisher"}, {"key": "p_87", "DOI": "10.1016/S0300-483X(98)00037-7", "doi-asserted-by": "publisher"}, {"key": "p_88", "DOI": "10.1074/jbc.273.35.22395", "doi-asserted-by": "publisher"}, {"key": "p_89", "DOI": "10.1073/pnas.91.1.133", "doi-asserted-by": "publisher"}, {"key": "p_90", "DOI": "10.1073/pnas.94.19.10346", "doi-asserted-by": "publisher"}, {"key": "p_91", "author": "Murata M", "volume": "1999", "first-page": "1113", "year": "1998", "journal-title": "Drug Metab Dispos"}, {"key": "p_92", "author": "Murata M", "volume": "1999", "first-page": "79", "year": "1999", "journal-title": "J Pharmacol Exp Ther"}], "container-title": ["The Blood-Brain Barrier and Drug Delivery to the CNS"], "link": [{"URL": "http://www.crcnetbase.com/doi/pdf/10.1201/9780824741990.ch8", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 9, 8]], "date-time": "2016-09-08T21:50:48Z", "timestamp": 1473371448000}, "score": 36.422253, "issued": {"date-parts": [[2000, 5, 16]]}, "ISBN": ["9780824703943", "9780824741990"], "references-count": 92, "alternative-id": ["10.1201/9780824741990.ch8", "10.1201/9780824741990"], "URL": "http://dx.doi.org/10.1201/9780824741990.ch8", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:31:58Z", "timestamp": 1574137918762}, "publisher-location": "New Jersey", "reference-count": 0, "publisher": "Humana Press", "isbn-type": [{"value": "1592598544", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1385/1-59259-854-4:237", "type": "book-chapter", "created": {"date-parts": [[2004, 9, 16]], "date-time": "2004-09-16T19:00:07Z", "timestamp": 1095361207000}, "page": "237-252", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Transport of Antisense Across the Blood\u2013Brain Barrier"], "prefix": "10.1007", "author": [{"given": "Laura B.", "family": "Jaeger", "sequence": "first", "affiliation": []}, {"given": "William A.", "family": "Banks", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Antisense Therapeutics"], "deposited": {"date-parts": [[2013, 1, 3]], "date-time": "2013-01-03T13:56:37Z", "timestamp": 1357221397000}, "score": 36.35842, "issued": {"date-parts": [[null]]}, "ISBN": ["1592598544"], "references-count": 0, "URL": "http://dx.doi.org/10.1385/1-59259-854-4:237"}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:54:02Z", "timestamp": 1574099642950}, "reference-count": 50, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 4, 1]], "date-time": "2001-04-01T00:00:00Z", "timestamp": 986083200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Brain Research"], "published-print": {"date-parts": [[2001, 4]]}, "DOI": "10.1016/s0006-8993(01)02242-9", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T17:08:20Z", "timestamp": 1027616900000}, "page": "209-217", "source": "Crossref", "is-referenced-by-count": 91, "title": ["Enhanced leptin transport across the blood\u2013brain barrier by \u03b11-adrenergic agents"], "prefix": "10.1016", "volume": "899", "author": [{"given": "William A", "family": "Banks", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Brain Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0006899301022429?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0006899301022429?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 25]], "date-time": "2019-04-25T07:28:41Z", "timestamp": 1556177321000}, "score": 36.208088, "issued": {"date-parts": [[2001, 4]]}, "references-count": 50, "journal-issue": {"published-print": {"date-parts": [[2001, 4]]}, "issue": "1-2"}, "alternative-id": ["S0006899301022429"], "URL": "http://dx.doi.org/10.1016/s0006-8993(01)02242-9", "ISSN": ["0006-8993"], "issn-type": [{"value": "0006-8993", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T10:50:02Z", "timestamp": 1574506202569}, "reference-count": 38, "publisher": "Wiley", "issue": "12", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 6483, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1997, 12]]}, "DOI": "10.1111/j.2042-7158.1997.tb06072.x", "type": "journal-article", "created": {"date-parts": [[2011, 4, 12]], "date-time": "2011-04-12T22:54:52Z", "timestamp": 1302648892000}, "page": "1211-1216", "source": "Crossref", "is-referenced-by-count": 97, "title": ["Molecular Factors Influencing Drug Transfer across the Blood-Brain Barrier"], "prefix": "10.1111", "volume": "49", "author": [{"given": "JULIE A.", "family": "GRATTON", "sequence": "first", "affiliation": []}, {"given": "MICHAEL H.", "family": "ABRAHAM", "sequence": "additional", "affiliation": []}, {"given": "MICHAEL W.", "family": "BRADBURY", "sequence": "additional", "affiliation": []}, {"given": "HARPREET S.", "family": "CHADHA", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2011, 4, 12]]}, "reference": [{"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1039/cs9932200073", "article-title": "Scales of solute hydrogen-bonding: their construction application to physicochemical and biochemical processes", "volume": "22", "author": "Abraham", "year": "1993", "journal-title": "Chem. Soc. Rev."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB2|cit2", "author": "Abraham", "first-page": "311", "year": "1996", "volume-title": "Lipophilicity in Drug Action and Toxicity", "DOI": "10.1002/9783527614998.ch18", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1007/BF02311772", "article-title": "The use of characteristic volumes to measure cavity terms in reversed phase liquid chromatography", "volume": "23", "author": "Abraham", "year": "1987", "journal-title": "Chromatographia"}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1450", "DOI": "10.1002/jps.2600831017", "article-title": "Hydrogen bonding 30. The solubility of gases and vapors in biological liquids and tissues", "volume": "83", "author": "Abraham", "year": "1994", "journal-title": "J. Pharm. Sci."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1257", "DOI": "10.1002/jps.2600830915", "article-title": "Hydrogen bonding. Part 33. The factors that influence the distribution of solutes between blood and brain", "volume": "83", "author": "Abraham", "year": "1994a", "journal-title": "J. Pharm. Sci."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "1085", "DOI": "10.1002/jps.2600830806", "article-title": "Hydrogen bonding Part 32. An analysis of water-octanol and water-alkane partitioning and the (logP parameter of Seiler", "volume": "83", "author": "Abraham", "year": "1994b", "journal-title": "J. Pharm. Sci."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.1111/j.2042-7158.1995.tb05725.x", "article-title": "The factors that influence the skin permeation of solutes", "volume": "47", "author": "Abraham", "year": "1995", "journal-title": "J. Pharm. Pharmacol."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB8|cit8", "first-page": "381", "article-title": "Pharmacology of the specific H1 antagonist, astemizole", "volume": "33", "author": "Awouters", "year": "1983", "journal-title": "Arzneim. Forsch."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB9|cit9", "author": "Bradbury", "year": "1979", "volume-title": "The Concept of a Blood-Brain Barrier"}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "648", "DOI": "10.1083/jcb.40.3.648", "article-title": "Junctions between intimately apposed cell membranes in the vertebrate brain", "volume": "40", "author": "Brightman", "year": "1969", "journal-title": "J. Cell. Biol."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "412", "DOI": "10.1023/A:1018969222130", "article-title": "Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides", "volume": "11", "author": "Chikhale", "year": "1994", "journal-title": "Pharm. Res."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB12|cit12", "first-page": "298", "article-title": "The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism", "volume": "273", "author": "Chikhale", "year": "1995", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB13|cit13", "author": "Davson", "year": "1943", "volume-title": "The Permeability of Natural Membranes"}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "905", "DOI": "10.1111/j.1471-4159.1990.tb02337.x", "article-title": "Transport of lead-203 at the blood-brain barrier during short cerebrovascular perfusion with saline in the rat", "volume": "54", "author": "Deane", "year": "1990", "journal-title": "J. Neurochem."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB15|cit15", "author": "Dearden", "volume": "64", "first-page": "375", "year": "1990", "volume-title": "Comprehensive Medicinal Chemistry"}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB16|cit16", "author": "Fenstermacher", "volume": "Vol. IV", "first-page": "969", "year": "1984", "volume-title": "Handbook of Physiology, The Cerebrovascular System"}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "1089", "DOI": "10.1046/j.1471-4159.1994.62031089.x", "article-title": "Localization of drug metabolizing enzyme activities to blood-brain interfaces and circumventricular organs", "volume": "62", "author": "Ghersiegea", "year": "1994", "journal-title": "J. Neurochem."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1113/jphysiol.1993.sp019880", "article-title": "Transport into retina measured by short vascular perfusion in the rat", "volume": "470", "author": "Gratton", "year": "1993", "journal-title": "J. Physiol."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "1765", "DOI": "10.1021/cr00098a007", "article-title": "QSAR studies of drugs acting on the central nervous system", "volume": "89", "author": "Gupta", "year": "1989", "journal-title": "Chem. Rev."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1021/jm00307a001", "article-title": "The parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics", "volume": "11", "author": "Hansen", "year": "1968", "journal-title": "J. Med. Chem."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.1002/jps.2600760902", "article-title": "Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drag design", "volume": "76", "author": "Hansch", "year": "1987", "journal-title": "J. Pharm. Sci."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB22|cit22", "first-page": "1649", "article-title": "(R68553), a novel type of antidiarrheal agent", "volume": "24", "author": "Heykants", "year": "1974", "journal-title": "Arzneim. Forsch."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "140", "DOI": "10.1098/rspb.1946.0008", "article-title": "The active and passive exchanges of inorganic ions through the surfaces of living cells and through living membranes generally", "volume": "133", "author": "Krogh", "year": "1946", "journal-title": "Proc. R. Soc. Biol."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB24|cit24", "first-page": "294", "article-title": "In-vitro and in-vivo binding characteristics of a new histamine H1 antagonist, astemizole", "volume": "26", "author": "Laduron", "year": "1982", "journal-title": "Mol. Pharmacol."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "682", "DOI": "10.1021/jm00180a022", "article-title": "Relationship of octanol water partition coefficient and molecular weight to rat brain permeability", "volume": "23", "author": "Levin", "year": "1980", "journal-title": "J. Med. Chem."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB26|cit26", "first-page": "205", "article-title": "Kinetics of penetration of drugs and other foreign compounds into cerebrospinal fluid and brain", "volume": "127", "author": "Mayer", "year": "1959", "journal-title": "J. Pharmacol."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB27|cit27", "first-page": "H299", "article-title": "Lower limits of cerebrovascular permeability to non-electrolytes in the conscious rat", "volume": "253", "author": "Ohno", "year": "1978", "journal-title": "Am. J. Phys."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "1481", "DOI": "10.1152/physrev.1983.63.4.1481", "article-title": "Brain metabolism: a perspective from the blood-brain barrier", "volume": "63", "author": "Pardridge", "year": "1983", "journal-title": "Physiol. Rev."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB29|cit29", "first-page": "884", "article-title": "Comparison of in-vitro and in-vivo models of drug transcytosis through the blood-brain barrier", "volume": "253", "author": "Pardridge", "year": "1990", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.2214/ajr.122.1.186", "article-title": "Neurotoxicity of X-ray contrast media: relation to lipid solubility and blood brain barrier permeability", "volume": "122", "author": "Rapoport", "year": "1974", "journal-title": "Am. J. Roentgenol."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1083/jcb.34.1.207", "article-title": "Fine structural localization of the blood-brain barrier to exogenous peroxidase", "volume": "34", "author": "Reese", "year": "1967", "journal-title": "J. Cell Biol."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "1205", "DOI": "10.1152/ajplegacy.1959.197.6.1205", "article-title": "Transport of potassium-42 from blood to tissue in isolated skeletal muscles", "volume": "197", "author": "Renkin", "year": "1959", "journal-title": "Am. J. Phys."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1073/pnas.91.1.68", "article-title": "A method to determine the ability of drags to diffuse through the blood-brain barrier", "volume": "91", "author": "Seelig", "year": "1994", "journal-title": "Proc. Natl Acad. Sci."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB34|cit34", "first-page": "473", "article-title": "Interconversion of lipophilicities from hydrocarbon/water systems into the octanol/water system", "volume": "9", "author": "Seiler", "year": "1974", "journal-title": "Eur. J. Med. Chem."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB35|cit35", "author": "Smith", "volume": "6", "first-page": "85", "year": "1989", "volume-title": "Implications of the Blood-Brain Barrier and its Manipulation", "DOI": "10.1007/978-1-4613-0701-3_4", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB36|cit36", "first-page": "H484", "article-title": "An in situ perfusion technique to study cerebrovascular permeability in the rat", "volume": "247", "author": "Takasato", "year": "1984", "journal-title": "Am. J. Phys."}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB37|cit37", "first-page": "224", "article-title": "Transport in QSAR IV. The interfacial drug transfer model. Relationships between partition coefficients and rate constants in drag partitioning", "volume": "3", "author": "Waterbeemd", "year": "1981", "journal-title": "Pharm. Weekbl. [Sci.]"}, {"key": "10.1111/j.2042-7158.1997.tb06072.x-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1021/jm00398a028", "article-title": "Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists", "volume": "31", "author": "Young", "year": "1988", "journal-title": "J. Med. Chem."}], "container-title": ["Journal of Pharmacy and Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.2042-7158.1997.tb06072.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 10]], "date-time": "2019-06-10T00:09:29Z", "timestamp": 1560125369000}, "score": 36.096325, "issued": {"date-parts": [[1997, 12]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[1997, 12]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.1111/j.2042-7158.1997.tb06072.x", "relation": {"cites": []}, "ISSN": ["0022-3573"], "issn-type": [{"value": "0022-3573", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T04:10:22Z", "timestamp": 1574309422487}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Delivery"], "published-print": {"date-parts": [[1998, 1]]}, "DOI": "10.3109/10717549809031391", "type": "journal-article", "created": {"date-parts": [[2009, 7, 2]], "date-time": "2009-07-02T11:57:54Z", "timestamp": 1246535874000}, "page": "153-153", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Drug transport across the blood\u2013Brain barrier: In Vitro and In Vivo techniques"], "prefix": "10.1080", "volume": "5", "author": [{"given": "de Boer A.", "family": "G", "sequence": "first", "affiliation": []}, {"given": "W.", "family": "Sutanto", "sequence": "additional", "affiliation": []}, {"given": "William M.", "family": "Pardridge", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7, 2]]}, "container-title": ["Drug Delivery"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.3109/10717549809031391", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T07:49:27Z", "timestamp": 1481615367000}, "score": 36.02004, "issued": {"date-parts": [[1998, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 7, 2]]}, "published-print": {"date-parts": [[1998, 1]]}, "issue": "2"}, "alternative-id": ["10.3109/10717549809031391"], "URL": "http://dx.doi.org/10.3109/10717549809031391", "ISSN": ["1071-7544", "1521-0464"], "issn-type": [{"value": "1071-7544", "type": "print"}, {"value": "1521-0464", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}